09.02.2013 Views

GAMeets - the Instituto Gulbenkian de Ciência - Fundação Calouste ...

GAMeets - the Instituto Gulbenkian de Ciência - Fundação Calouste ...

GAMeets - the Instituto Gulbenkian de Ciência - Fundação Calouste ...

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

GULBENKIAN ALUMNI MEETINGS<br />

(<strong>GAMeets</strong>)<br />

6th Edition<br />

15th Anniversary of <strong>the</strong> Cúria Meetings<br />

Palace Hotel Cúria<br />

27-28 December 2010<br />

1


Welcome!<br />

This year, we have ma<strong>de</strong> great efforts to bring you all to Curia.<br />

Not only to reminisce of those “gol<strong>de</strong>n” days in <strong>the</strong> past of course,<br />

but most specially to contribute to <strong>the</strong> continuation of our future. We<br />

hope that <strong>the</strong>se two days that we spend toge<strong>the</strong>r will foster many<br />

future collaborations, scientific and o<strong>the</strong>r, thus streng<strong>the</strong>ning our<br />

network as it proliferates through our new entrants, many for whom,<br />

Curia this year is <strong>the</strong> very first time, and to whom we warmly<br />

welcome and hope that this event and this singular location will be<br />

enjoyed in just <strong>the</strong> same manner as it was in <strong>the</strong> past!<br />

Monica Dias, Sofia Araujo and Greta Martins<br />

Some important links for networking:<br />

IGC Facebook<br />

http://www.facebook.com/<strong>Instituto</strong><strong>Gulbenkian</strong>Ciencia<br />

IGC PhD Alumni Facebook Group<br />

http://www.facebook.com/home.php?sk=group_178917335470253<br />

2


MONDAY 27 DECEMBER<br />

Programme<br />

Morning: Arrivals and check-in at <strong>the</strong> Curia Palace Hotel<br />

12h30: Lunch and Opening Session<br />

14h00: SESSION ONE<br />

PGDBM2 - Cláudio Gomes, Margarida Trinda<strong>de</strong>,<br />

Guilherme Neves. PGDB2 - David Cristina, Helena<br />

Soares, Eduardo Silva. PGDB4 - Joana Sá, Paulo<br />

Ribeiro, Tiago Carvalho. PGDBM3 - Pedro Brites,<br />

Perpetua Ó, José Leal. PIBS - Lilia Perfeito, Dinis<br />

Calado, Cristina Borges. PGDBM4 - Alexandra<br />

Capela, Carla Martins. PDBC - Isabel Duarte.<br />

16h30: SESSION TWO: Coffee Break and Poster Session<br />

Mónica Bettencourt-Dias, Sofia Araújo, Ana Teresa<br />

Tavares, Pedro Domingos, Ofélia Carvalho, Francisco<br />

Dionísio, Marta Nunes, Vera Teixeira, Rui Peixoto,<br />

Daniel Sobral, Ulla-Maj Fiuza, Paula Duque, Greta<br />

Martins.<br />

18h00: SESSION THREE<br />

PGDB1 - Vanessa Zuzarte, Miguel Gaspar, Luís<br />

Soares. PGDB5 - Ana Mateus, Ricardo Silva, Catia<br />

Proença. PGDB3 - César Evaristo, José Antão,<br />

Catarina Homem. PGDBM5 - Bruno Silva-Santos, Rita<br />

Nunes, Susana Nery, Isabel Gordo. PGDMB6 - Rita<br />

Teodoro, Luis Teixeira. PGDBM7 - Tiago Carneiro, Mª<br />

João Leão<br />

20h30: Dinner<br />

3


22h00: Jonathan Howard,<br />

TUESDAY 28 DECEMBER<br />

University of Cologne, Germany and IGC SAB Member<br />

“How to build a perfect institute”<br />

9h30-10h40: SESSION FOUR<br />

PGDBM1- António Jacinto, Luís Martins, José Belo,<br />

Isabel Palmeirim, PGFMA-Ana Cer<strong>de</strong>ira, Sofia Braga,<br />

INDP-Maria Inês Vicente, Pedro Ferreira.<br />

10h45-11h00: Coffee break<br />

11h00-12h00: Maria Leptin, Director, EMBO, Germany<br />

“My Life in Science”<br />

12h00-12h30: Closing Session:<br />

António Coutinho, IGC and Diogo Lucena, FCG<br />

13h00: Lunch – Leitão at Anadia Museum<br />

4


ABSTRACTS FOR ORAL PRESENTATIONS<br />

Monday 27 December<br />

SESSION ONE<br />

6


Protein <strong>de</strong>position pathways at <strong>the</strong> synaptic milieu<br />

Claudio M. Gomes<br />

<strong>Instituto</strong> <strong>de</strong> Tecnologia Química e Biológica, Universida<strong>de</strong> Nova <strong>de</strong><br />

Lisboa, Oeiras<br />

My laboratory investigates <strong>the</strong> biology and biophysics of protein<br />

folding, <strong>the</strong> essential cellular process through which proteins acquire<br />

a functional conformation. In recent years we have addressed how<br />

this process is affected in neuro<strong>de</strong>generative and metabolic diseases,<br />

resulting in protein misfolding or aggregation (1-3). Protein<br />

<strong>de</strong>position as amyloid oligomers in <strong>the</strong> human nervous system is<br />

characteristic of neuro<strong>de</strong>generative diseases such as Alzheimer’s and<br />

Parkinson’s. The i<strong>de</strong>ntification of cellular modulators of protein<br />

<strong>de</strong>position remains a challenging issue, which has been <strong>the</strong> focus of<br />

our recent attention.<br />

In this brief talk I will overview our approach to un<strong>de</strong>rstand <strong>the</strong><br />

biology and mechanisms of protein aggregation in <strong>the</strong> nervous<br />

system. In particular I will focus on <strong>the</strong> role played by <strong>the</strong> unique<br />

chemical biology of <strong>the</strong> synaptic environment, namely high<br />

concentrations of metal ions and secreted proteins in a molecular and<br />

physically confined environment. To illustrate this aspect I will<br />

overview our recent progresses on <strong>the</strong> analysis of amyloid formation<br />

by S100 proteins, which are upregulated in <strong>the</strong> brain in amyloid<br />

diseases (Alzheimer’s and ALS), and <strong>the</strong> cross talk with <strong>the</strong> amyloidbeta<br />

pepti<strong>de</strong> un<strong>de</strong>r conditions mimicking <strong>the</strong> synaptic environment<br />

(4).<br />

1. Kim, S., Leal, S. S., Ben Halevy, D., Gomes, C. M., and Lev, S.<br />

(2010) J Biol Chem 285(18), 13839-13849<br />

2. Henriques, B. J., Rodrigues, J. V., Olsen, R. K., Bross, P., and<br />

Gomes, C. M. (2009) J Biol Chem 284(7), 4222-4229<br />

3. Correia, A. R., Adinolfi, S., Pastore, A., and Gomes, C. M. (2006)<br />

Biochem J 398(3), 605-611<br />

4. Fritz, G., Botelho, H. M., Morozova Roche, L., and Gomes, C. M.<br />

(2010) FEBS J, in press<br />

8


Science is funding<br />

Margarida Trinda<strong>de</strong><br />

<strong>Instituto</strong> <strong>de</strong> Medicina Molecular, Faculda<strong>de</strong> <strong>de</strong> Medicina da<br />

Universida<strong>de</strong> <strong>de</strong> Lisboa<br />

Margarida Trinda<strong>de</strong> is currently responsible for Science Funding, at<br />

<strong>the</strong> Communication and Training Unit at <strong>the</strong> <strong>Instituto</strong> <strong>de</strong> Medicina<br />

Molecular (IMM) in Lisbon. Her current responsibilities inclu<strong>de</strong><br />

supporting researchers assembling national and international<br />

research funding proposals, grant application management, contract<br />

negotiation and training on grant writing for graduate stu<strong>de</strong>nts. At<br />

<strong>the</strong> interface of <strong>the</strong> Institute’s administrative services and <strong>the</strong><br />

researchers, Margarida’s goal is to foster an environment for<br />

additional science funding at IMM.<br />

9


TRANSGENIC MICE<br />

Guilherme Neves (1) Mala Shah (2) Petros Liodis (1) and Vassilis<br />

Pachnis (1)<br />

(1) Molecular Neurobiology Division, NIMR, London, UK<br />

(2) The School of Pharmacy, UCL, London, UK<br />

Defects in inhibitory circuits in <strong>the</strong> cortex often un<strong>de</strong>rpin <strong>the</strong> emersion<br />

of seizure activity. However <strong>the</strong> relative importance of somatic versus<br />

<strong>de</strong>ndritic inhibition in <strong>the</strong> pathogenesis of epilepsy remains unclear.<br />

The LIM homeodomain transcription factor Lhx6 is essential for <strong>the</strong><br />

differentiation of <strong>the</strong> parvalbumin (Pva) and somatostatin (Sst)<br />

expressing subpopulations of GABAergic interneurons, and for <strong>the</strong><br />

normal <strong>de</strong>velopment of inhibitory circuits in <strong>the</strong> mouse cortex. Null<br />

mutations in Lhx6 result in a pronounced <strong>de</strong>ficit in synaptic inhibition<br />

and anatomical signs of severe seizure activity. Interestingly,<br />

hypomorphic Lhx6 mutants show a remarkably selective <strong>de</strong>ficit in <strong>the</strong><br />

differentiation of Sst+ interneurons. Moreover, <strong>the</strong>se animals show<br />

behavioural, histological and electroencephalographic signs of<br />

recurrent seizure activity, starting from early adulthood. Consistent<br />

with a selective <strong>de</strong>fect in <strong>the</strong> differentiation of Sst+ interneurons,<br />

which project primarily to <strong>the</strong> <strong>de</strong>ndritic compartment of principal<br />

neurons, we have observed characteristic <strong>de</strong>ficits in <strong>de</strong>ndritic<br />

inhibition but normal inhibitory input onto <strong>the</strong> somatic compartment<br />

of pyramidal cells. These data implicate <strong>the</strong> Sst+ interneuron<br />

population as an important control system that normally prevents <strong>the</strong><br />

emergence of seizure activity.<br />

10


Technology Transfer in <strong>the</strong> Greater Lisbon Area<br />

David Cristina, Bruno Reynolds, Lígia Martins and António Coutinho<br />

IGC, ITQB<br />

Technology Transfer (TT) is <strong>the</strong> exploitation, commercial or<br />

o<strong>the</strong>rwise, of scientific research for <strong>the</strong> direct benefit of society. It's<br />

activities inclu<strong>de</strong> sourcing invention disclosures, guaranteeing patent<br />

protection, licensing technologies, forming spin-out companies and<br />

managing consultancy opportunities for scientists. The quality of<br />

Portuguese Life Sciences research has increased significantly over <strong>the</strong><br />

last 10 years, however <strong>the</strong> TT structures have not kept up with this<br />

<strong>de</strong>velopment. As part of our project, we are <strong>de</strong>veloping a TT Office<br />

addressing this specific need for <strong>the</strong> Greater Lisbon area. We are<br />

doing this by analyzing different international TT mo<strong>de</strong>ls and<br />

adjusting <strong>the</strong>m to <strong>the</strong> national context. We have already started<br />

providing services to researchers and, so far, we have been able to<br />

assist in <strong>the</strong> formation of a "start-up", Acellera Therapeutics.<br />

11


Hierarchically regulated exocytosis controls signal amplification at <strong>the</strong><br />

immunological synapse and is targeted by HIV-1<br />

Helena Martins Soares (1) Françoise Porrot (2) Olivier Schwartz (2)<br />

Maria-Isabel Thoulouze (1) and Andrés Alcover (1)<br />

(1) Lymphocyte Cell Biology Unit<br />

(2) Virus an Immunity Unit. Institut Pasteur<br />

T cell receptor (TCR) signaling is triggered and controlled at<br />

immunological synapses. TCR and signaling effectors concentrate at<br />

<strong>the</strong> synapse, form dynamic signaling clusters, being <strong>the</strong>n differentially<br />

sorted. This facilitates <strong>the</strong> induction, amplification and extinction of<br />

TCR signaling that drives T cell activation. Intracellular vesicle<br />

transport targets <strong>the</strong> TCR, <strong>the</strong> tyrosine kinase Lck and <strong>the</strong> adaptor<br />

LAT to <strong>the</strong> synapse, but <strong>the</strong> regulation of this transport and its<br />

significance for TCR signaling remain unknown. We show that HIV-1<br />

dissects this vesicle transport unveiling that Lck, TCR and LAT are in<br />

distinct vesicular compartments that concomitantly polarize to <strong>the</strong><br />

synapse. Lck compartment fuses first with <strong>the</strong> plasma membrane in a<br />

calcium-in<strong>de</strong>pen<strong>de</strong>nt manner, <strong>the</strong>n regulating <strong>the</strong> calcium-<strong>de</strong>pen<strong>de</strong>nt<br />

fusion of TCR and LAT compartments, and <strong>the</strong> subsequent LAT<br />

phosphorylation. Therefore, a hierarchically regulated exocytocitic<br />

process drives signal amplification at <strong>the</strong> immunological synapse.<br />

HIV-1 breaks this process by retaining Lck in endosomes <strong>the</strong>refore<br />

uncoupling LAT from <strong>the</strong> TCR.<br />

12


Material Systems for targeting and reversing ischemia<br />

Eduardo A. Silva<br />

Wyss Institute for Biologically Inspired Engineering - Harvard<br />

University<br />

Spatially and temporally regulated signaling between and within cell<br />

populations and <strong>the</strong> extracellular matrix regulate tissue homeostasis,<br />

pathology and regeneration, and polymeric materials that can mimic<br />

or enhance this communication have <strong>the</strong> potential to intervene in<br />

<strong>the</strong>se processes in a <strong>the</strong>rapeutic manner. These cell instructive<br />

polymer systems provi<strong>de</strong> insoluble signaling molecules and cues<br />

(e.g., adhesion pepti<strong>de</strong>s) or soluble signaling molecules (e.g., growth<br />

factors) alone or in specific combinations to ei<strong>the</strong>r host tissue cells or<br />

to transplanted cells to regulate <strong>the</strong>ir activation, multiplication and<br />

differentiation. Multiple aspects of regeneration must be consi<strong>de</strong>red to<br />

<strong>de</strong>sign effective approaches to enable functional tissue replacement,<br />

and this issue has been addressed in <strong>the</strong> context of angiogenesis. The<br />

systems <strong>de</strong>scribed in this research could represents an attractive new<br />

generation of <strong>the</strong>rapeutic <strong>de</strong>livery vehicle for treatment of<br />

cardiovascular diseases, as it combines long term in vivo <strong>the</strong>rapeutic<br />

benefit with minimally invasive <strong>de</strong>livery.<br />

13


Dead mules: when strong post-zygotic isolation is not sufficient to<br />

prevent mating<br />

Joana Gonçalves-Sá (1,2,3) and Andrew Murray (1,2)<br />

(1) MCB, Harvard University, Cambridge, MA 02138, USA<br />

(2) FAS Center for Systems Biology, Harvard University, Cambridge,<br />

MA 02138, USA<br />

(3) <strong>Gulbenkian</strong> Ph.D. Program in Biomedicine, IGC, Oeiras, Portugal<br />

Speciation, <strong>the</strong> paradigm has it, happens when two populations can<br />

no longer interbreed and give rise to fertile progeny. Thus, <strong>the</strong><br />

prediction is that if two species share an ecological niche and <strong>the</strong>ir<br />

hybrids have very strong fitness <strong>de</strong>fects, <strong>the</strong>re would be an<br />

advantage in evolving mechanisms to prevent mating events between<br />

<strong>the</strong>m.<br />

In Saccharomyces cerevisiae mating occurs when two haploid cells of<br />

opposite mating types fuse. The two cells communicate through<br />

secreted pheromones and <strong>the</strong> corresponding transmembrane<br />

receptors and we asked whe<strong>the</strong>r, like in o<strong>the</strong>r species, receptor<br />

specificity could be playing a role in reproductive isolation.<br />

We looked at <strong>the</strong> evolution of <strong>the</strong> specificity of <strong>the</strong> pepti<strong>de</strong> receptor<br />

Ste2 in <strong>the</strong> phylum Ascomycota. We i<strong>de</strong>ntified Ste2-like receptors<br />

from different species and expressed a subset of <strong>the</strong>m in S.<br />

cerevisiae. Thirteen of <strong>the</strong> heterologously expressed receptors<br />

successfully respon<strong>de</strong>d to self-pheromone and some of <strong>the</strong>m are<br />

surprisingly promiscuous and can respond to high concentrations of<br />

pheromones from different species. We see no evi<strong>de</strong>nce of positive<br />

selection in <strong>the</strong> pheromone receptors contrasting with previous<br />

studies of genes involved in speciation, and this can explain <strong>the</strong><br />

cross-talk between different receptors and pheromones.<br />

We tested whe<strong>the</strong>r this lack of specificity could be enough to allow<br />

<strong>de</strong>tection, recognition and mating. We crossed two sympatric species,<br />

S. cerevisiae and S. castellii and observed that <strong>the</strong>y can fuse at high<br />

frequency but no viable diploids are formed in <strong>the</strong> process.<br />

We conclu<strong>de</strong> that in <strong>the</strong> Saccharomyces, speciation is most likely not<br />

happening at <strong>the</strong> receptor/pheromone recognition level and that, in<br />

<strong>the</strong>se species, strong post-zygotic isolation is not sufficient to prevent<br />

mating.<br />

14


Regulation of tissue growth in Drosophila<br />

Paulo S. Ribeiro<br />

Postdoctoral Fellow<br />

Tapon Lab - Apoptosis and Proliferation Control Laboratory<br />

Cancer Research UK, London Research Institute<br />

44 Lincoln’s Inn Fields<br />

London WC2A 3LY<br />

United Kingdom<br />

Metazoan organ <strong>de</strong>velopment requires strict control of cell<br />

proliferation, growth and <strong>de</strong>ath. Studies in Drosophila have i<strong>de</strong>ntified<br />

a novel signalling pathway, <strong>the</strong> Hippo (Hpo) pathway, which is<br />

required for tissue size control as it inhibits proliferation and<br />

promotes apoptosis. Since many of <strong>the</strong> pathways that limit tissue size<br />

during <strong>de</strong>velopment also function in adults, <strong>the</strong>y are often <strong>the</strong> targets<br />

of cancer-causing alterations. Hpo pathway members are highly<br />

conserved and, <strong>de</strong>pending on <strong>the</strong>ir function, can act as tumour<br />

suppressors or oncogenes in mammals.<br />

The Hpo pathway consists of a kinase casca<strong>de</strong> comprising <strong>the</strong> kinases<br />

Hpo and Warts (Wts), which culminates in <strong>the</strong> inhibition of Yorkie<br />

(Yki), a growth-promoting transcriptional co-activator involved in<br />

tumourigenesis. Hpo signalling is also regulated by upstream<br />

members, such as <strong>the</strong> atypical cadherin Fat, <strong>the</strong> cytoskeletal band<br />

4.1 proteins Expan<strong>de</strong>d (Ex) and Merlin (Mer), and <strong>the</strong> newly i<strong>de</strong>ntified<br />

Kibra. Moreover, <strong>the</strong> kinase adaptor proteins Mats, Salvador (Sav)<br />

and dRASSF can also control <strong>the</strong> activity of <strong>the</strong> pathway. Although<br />

some of <strong>the</strong> major pathway components are known, <strong>the</strong> molecular<br />

mechanisms regulating Hpo signalling activity are still unclear. In<br />

particular, little is known about <strong>the</strong> negative regulation of <strong>the</strong> kinase<br />

casca<strong>de</strong> that lies at <strong>the</strong> core of <strong>the</strong> Hpo pathway.<br />

Using Drosophila as a mo<strong>de</strong>l system, we have recently characterised<br />

<strong>the</strong> in vivo and molecular functions of a PP2A phosphatase complex<br />

that negatively regulates Hpo signalling, which was i<strong>de</strong>ntified using<br />

combined high-throughput genomic and proteomic approaches.<br />

We will discuss <strong>the</strong>se new findings and <strong>the</strong> future of Hpo pathway<br />

research.<br />

15


Laboratory Or<strong>de</strong>rs: how to enjoy 2 extra weeks of vacation<br />

Tiago P. Carvalho<br />

PetriDish Software Lda.<br />

After completing his PhD in 2009, Tiago <strong>de</strong>ci<strong>de</strong>d to return to Portugal<br />

to start "something" <strong>the</strong>re. That "something" is now PetriDish<br />

Software Lda., a software company located at <strong>the</strong> Science and<br />

Technology Park of <strong>the</strong> University of Porto (UPTEC).<br />

The name of <strong>the</strong> company is homage to Julius Richard Petri, who<br />

invented <strong>the</strong> Petri dishes, while he was working as a research<br />

assistant in <strong>the</strong> laboratory of <strong>the</strong> not-less-famous Robert Koch. Petri<br />

dishes are a simple but brilliant invention, and <strong>the</strong>ir quick adoption<br />

ma<strong>de</strong> some laboratory practices so straightforward that today one<br />

rarely thinks about <strong>the</strong> difficulties that existed before Petri dishes<br />

were invented.<br />

Similarly, PetriDish Software is <strong>de</strong>voted to <strong>the</strong> <strong>de</strong>velopment and<br />

implementation of simple but smart software solutions. We humbly<br />

aim at making a Scientist\'s life so much easier, to <strong>the</strong> point that one<br />

day no one will un<strong>de</strong>rstand how it would be possible to work without<br />

some of our software solutions.<br />

Or<strong>de</strong>ring laboratory products or reagents is perceived by <strong>the</strong><br />

Scientific community as an annoying and time-consuming process.<br />

Our first product is <strong>the</strong> LabOr<strong>de</strong>rs online platform, which makes that<br />

process easier, faster, cheaper and more efficient (at<br />

http://www.labor<strong>de</strong>rs.com).<br />

In this talk I will present LabOr<strong>de</strong>rs live, while sharing <strong>the</strong> UPs and<br />

DOWNs of starting a company in Portugal<br />

16


The obscurity of plasmalogens in <strong>the</strong> spotlight<br />

Pedro Brites<br />

Nerve Regeneration Group, <strong>Instituto</strong> <strong>de</strong> Biologia Molecular e Celular,<br />

Porto, Portugal<br />

The importance of peroxisomes for normal function and physiology is<br />

highlighted by <strong>the</strong> severe disease sate, with severe pathology and<br />

poor outcome of patients with a disor<strong>de</strong>r caused by impaired<br />

peroxisomal function. Peroxisomes perform a myriad of functions that<br />

inclu<strong>de</strong> beta-oxidation of very-long-chain fatty acids, alpha-oxidation<br />

of phytanic acid, <strong>de</strong>gradation of hydrogen peroxi<strong>de</strong>, and <strong>the</strong><br />

biosyn<strong>the</strong>sis of plasmalogens (PLS).<br />

The peroxisomal disor<strong>de</strong>r, rhizomelic chondrodysplasia punctata<br />

(RCDP) is caused by <strong>the</strong> impairment in <strong>the</strong> biosyn<strong>the</strong>sis of PLS and is<br />

characterized by <strong>de</strong>fects in bone, eye and nervous tissue. PLS are<br />

e<strong>the</strong>r-phospholipids characterized by a vinyl-e<strong>the</strong>r bond at <strong>the</strong> sn-1<br />

position of <strong>the</strong> glycerol backbone. Despite an unclear physiologic<br />

function, PLS function as (i) <strong>de</strong>terminants of membrane structure and<br />

fluidity, (ii) pools of polyunsaturated fatty acids and (iii) scavengers<br />

of oxidative damage. Using mouse knockout mo<strong>de</strong>ls <strong>de</strong>ficient in PLS<br />

we aim at un<strong>de</strong>rstanding human disor<strong>de</strong>rs, characterize <strong>the</strong> <strong>de</strong>fects<br />

caused by a PLS <strong>de</strong>ficiency and <strong>de</strong>termine <strong>the</strong> mechanism and<br />

players involved in pathology caused by PLS <strong>de</strong>ficiency. Since<br />

nervous tissue is extremely rich in PLS we set out to characterize and<br />

<strong>de</strong>termine <strong>the</strong> role of PLS in neurons and in myelin. Our analysis<br />

revealed that in neurons a <strong>de</strong>ficiency in PLS causes abnormalities in<br />

<strong>the</strong> structure and patterning of neuromuscular junctions.<br />

A <strong>de</strong>ficiency in PLS also leads to abnormalities in myelin and in<br />

myelination characterized by <strong>de</strong>compaction of myelin sheaths and<br />

impaired myelination during <strong>de</strong>velopment, and after a lesion. Our<br />

results indicate that PLS are important structural components of<br />

membranes and that <strong>the</strong>ir <strong>de</strong>ficiency affects multiple processes. Due<br />

to <strong>the</strong>ir role in membranes, PLS may also modulate <strong>the</strong> disease state<br />

of non-peroxisomal disor<strong>de</strong>rs.<br />

17


At <strong>the</strong> Heart of INEB's Stem Cell Biology Team<br />

D.S. Nascimento, A. Freire, M. Valente and P.Pinto-do-Ó<br />

NEWTherapies Group, INEB - <strong>Instituto</strong> <strong>de</strong> Engenharia Biomédica,<br />

Universida<strong>de</strong> do Porto, Porto, Portugal<br />

Our team focus is on elucidating how stem/progenitor cells (SC)<br />

engage in regeneration and repair in adult-tissues. Special emphasis<br />

is placed on <strong>the</strong> mechanisms involved in <strong>the</strong> regulation of <strong>the</strong> socalled<br />

SC niches. Currently, <strong>the</strong> working paradigm is that of <strong>the</strong> heart<br />

as an organ endowed with endogenous cardiac stem/progenitor cell<br />

(CSC/CPC) population(s) and thus with self-regenerating potential.<br />

Myocardium-resi<strong>de</strong>nt putative CPCs display hallmarks of stemness<br />

and <strong>the</strong>ir antigenic profile, i.e. Sca+/c-Kit+/MDR1+, by matching that<br />

of o<strong>the</strong>r adult SC, raises <strong>the</strong> question as to whe<strong>the</strong>r CPCs originate in<br />

<strong>the</strong> heart or are continuously replenished from o<strong>the</strong>r organs. We<br />

address <strong>the</strong>se issues in an integrative manner. An experimental<br />

mouse-mo<strong>de</strong>l of myocardial infarction (MI) was established and a<br />

thorough cellular/molecular analysis of specific CPC-subsets is<br />

un<strong>de</strong>rway. Aiming at <strong>the</strong> i<strong>de</strong>ntification of molecules involved in CPCs<br />

stress-response signaling pathway(s), a series of transcripts have<br />

been serially evaluated in <strong>the</strong> Sca-1+ CPCs isolated from nonmanipulated,<br />

sham-operated and mice subjected to MI. At <strong>the</strong> tissuelevel,<br />

and to portray <strong>the</strong> CPCs, <strong>the</strong>ir differentiating progeny and<br />

supporting cells at <strong>the</strong> natural niche, protocols/tools for optimal in<br />

situ analysis have been a subject of continuous investment. Thus,<br />

from <strong>the</strong> digging and drawing of <strong>the</strong> cardiac stem/progenitor cells<br />

response(s) to heart injury a draft of (i) <strong>the</strong> kinetics of <strong>the</strong> cardiacniche’s<br />

composition and of (ii) <strong>the</strong> molecular blueprint of <strong>the</strong> CPC<br />

response to MI starts to emerge.<br />

18


From evolution to <strong>the</strong> bed-si<strong>de</strong><br />

Jose B. Pereira-Leal<br />

<strong>Instituto</strong> <strong>Gulbenkian</strong> <strong>de</strong> <strong>Ciência</strong> – Portugal<br />

Whe<strong>the</strong>r translational research should go from mechanistic cellular<br />

and molecular studies to its application, i.e. bench to <strong>the</strong> bed-si<strong>de</strong>, or<br />

from <strong>the</strong> clinical problem and human samples to <strong>the</strong> basic laboratory,<br />

i.e. bed-si<strong>de</strong> to <strong>the</strong> bench, is an issue that polarizes <strong>the</strong> biomedical<br />

community. I will discuss an example of a less explored translational<br />

avenue - from evolutionary studies to <strong>the</strong> bed-si<strong>de</strong>. In <strong>the</strong><br />

Computational Genomics Laboratory (evocell.org) of <strong>the</strong> Institute<br />

<strong>Gulbenkian</strong> <strong>de</strong> <strong>Ciência</strong> we are broadly interested in <strong>the</strong> evolutionary<br />

cell biology of cellular compartmentalization or modularity. We aim to<br />

un<strong>de</strong>rstand <strong>the</strong> evolutionary mechanisms by which cellular processes<br />

are physically separated, focusing on intracellular organelles. While<br />

studying <strong>the</strong> origin of bacterial-<strong>de</strong>rived organelles (e.g. mitochondria,<br />

chloroplasts, etc) we investigated <strong>the</strong> drivers of gene loss in<br />

intracellular parasites. We discovered that in addition to well-known<br />

drivers, e.g. no need for biosyn<strong>the</strong>tic pathways, <strong>the</strong>re is extensive<br />

loss of genetic redundancy.<br />

From an evolutionary perspective, our results support <strong>the</strong> notion that<br />

environmental predictability is a major driver of genome evolution.<br />

From a translational perspective, this discovery un<strong>de</strong>rpinned a new<br />

approach to drug repositioning, i.e. finding new uses for existing<br />

drugs, that already uncovered a new type of antibiotic. I will also<br />

discuss how o<strong>the</strong>r “evolutionary” projects in <strong>the</strong> lab are leading us to<br />

a translational context.<br />

19


Fitness Landscape of a Metabolic Pathway<br />

Lilia Perfeito (1,2) Stephane Ghozzi (2) Johannes Berg (2) Karin<br />

Schnetz (1) and Michael Laessig (2)<br />

(1) Institut für Genetik, Universitat zu Köln, Zälpicherstrasse 47a,<br />

50674 Cologne, Germany<br />

(2) Institut für Theoretische Physik, Universitat zu Köln,<br />

Zälpicherstrasse 77, 50937 Cologne, Germany<br />

In or<strong>de</strong>r to un<strong>de</strong>rstand how new functions evolve, it is important to<br />

know which phenotypes and un<strong>de</strong>r selection and how mutations<br />

affect <strong>the</strong>m. In this work, I show how this approach can be used to<br />

address <strong>the</strong> problem of <strong>the</strong> evolution of gene regulation. Genes are<br />

regulated because <strong>the</strong>ir expression involves a fitness cost to <strong>the</strong><br />

organism. The production of proteins by transcription and translation<br />

is a well-known cost factor, but <strong>the</strong> enzymatic activity of <strong>the</strong> proteins<br />

produced can also reduce fitness. We mapped <strong>the</strong> fitness costs of a<br />

key metabolic network, <strong>the</strong> lactose utilization pathway in Escherichia<br />

coli. We measured <strong>the</strong> growth of several regulatory lac operon<br />

mutants in different environments inducing expression of <strong>the</strong> lac<br />

genes. We find a strikingly nonlinear fitness landscape, which<br />

<strong>de</strong>pends on <strong>the</strong> production rate and on <strong>the</strong> activity rate of <strong>the</strong> lac<br />

proteins.<br />

A simple fitness mo<strong>de</strong>l of <strong>the</strong> lac pathway, based on elementary<br />

biophysical processes, predicts <strong>the</strong> growth rate of all observed<br />

strains. The nonlinearity of fitness is explained by a feedback loop:<br />

production and activity of <strong>the</strong> lac proteins reduce growth, but growth<br />

itself reduces <strong>the</strong> <strong>de</strong>nsity of <strong>the</strong>se molecules through dilution. This<br />

nonlinearity has important consequences for pathway function and<br />

evolution. It generates an activation threshold of <strong>the</strong> lac operon,<br />

above which bacterial growth abruptly drops to low values.<br />

Fur<strong>the</strong>rmore, <strong>the</strong> nonlinearity <strong>de</strong>termines how <strong>the</strong> fitness of operon<br />

mutants <strong>de</strong>pends on <strong>the</strong> inducer environment. Fitness nonlinearities,<br />

growth thresholds, and gene-environment interactions are likely<br />

generic features of metabolic pathways and have implications for <strong>the</strong><br />

evolution of regulation.<br />

20


NFκB signaling cooperates with cMyc to induce B cell transformation<br />

and multiple myeloma in <strong>the</strong> mouse<br />

Calado DP (1) Zhang B (1) Sasaki Y (2) Wun<strong>de</strong>rlich T (3)<br />

Schmidt Supprian M (4) and Rajewsky K (1)<br />

(1) PCMM/Immune Disease Institute, Harvard Medical School, Boston,<br />

USA<br />

(2) RIKEN Center for Developmental Biology, Kobe, Japan<br />

(3) The Institute of Genetics of <strong>the</strong> University of Cologne, Cologne,<br />

Germany<br />

(4) Max Planck Institute of Biochemistry, Munich, Germany<br />

Constitutive NFκB signaling and <strong>de</strong>regulation of cMyc expression are<br />

recurrent events in <strong>the</strong> ABC subgroup of Diffuse Large B cell<br />

Lymphoma (ABC/DLBCL), and in Multiple Myeloma (MM). However, it<br />

remains to be <strong>de</strong>termined whe<strong>the</strong>r constitutive NFκB signaling and<br />

<strong>de</strong>regulated cMyc expression, cooperate to induce B cell<br />

transformation and consequently are at <strong>the</strong> origin of ABC/DLBCL and<br />

or MM. To test this hypo<strong>the</strong>sis we used conditional targeted<br />

mutagenesis in <strong>the</strong> mouse, to express a constitutively active IKK2<br />

molecule and/or cMyc in CD19pos B cells through tamoxifen induced<br />

Cre mediated elimination of a STOP cassette. The genetic system of<br />

conditional targeted mutagenesis used in this work is unique in two<br />

ways. First, transgene activation occurs only in a small fraction of<br />

CD19pos B cells (3 to 5%) through transient Cre expression,<br />

mimicking <strong>the</strong> sporadic nature of oncogenic events. Second, due to<br />

incomplete Cre mediated recombination in individual cells, this<br />

CD19+ B cell population is constituted by IKK2capos/MYCpos,<br />

IKK2capos/MYCneg and IKK2caneg/MYCpos expressing cells,<br />

providing all possible “oncogene” combinations in <strong>the</strong> same mouse at<br />

<strong>the</strong> same time.<br />

We observed that 100% of <strong>the</strong> mice succumbed to a plasma cell<br />

neoplasia <strong>de</strong>rived from <strong>the</strong> IKK2capos/MYCpos population, with a<br />

median survival of 192 days. Thus, using a conditional targeted<br />

mutagenesis system that recapitulates <strong>the</strong> sporadic nature of<br />

oncogenic events, we <strong>de</strong>monstrate that constitutive NFκB signaling<br />

cooperates with <strong>de</strong>regulated cMyc expression to induce B cell<br />

transformation and MM in <strong>the</strong> mouse. These results suggest that this<br />

oncogene combination represents a primary event in MM ra<strong>the</strong>r than<br />

ABC/DLBCL.<br />

21


Tight Junction components: novel players in Epi<strong>the</strong>lial<br />

Morphogenesis?<br />

Ana Cristina Borges (1,2) Ana Cristina Silva (1,2) Jorge Carneiro<br />

(1) Mathias Koeppen (1) and António Jacinto (1,2)<br />

(1) <strong>Instituto</strong> <strong>Gulbenkian</strong> <strong>de</strong> Ciencia<br />

(2) <strong>Instituto</strong> <strong>de</strong> Medicina Molecular<br />

We are interested in <strong>the</strong> un<strong>de</strong>rstanding of <strong>the</strong> molecular mechanisms<br />

involved in <strong>the</strong> sealing of an epi<strong>the</strong>lial discontinuity that occur both in<br />

normal <strong>de</strong>velopment and eventually during tissue repair. We are<br />

using <strong>the</strong> zebrafish embryo as a mo<strong>de</strong>l system, since it allows <strong>the</strong><br />

study of <strong>the</strong> morphogenetic movements of epiboly and wound<br />

healing. In both cases, closure of <strong>the</strong> gap is achieved as <strong>the</strong> opposing<br />

tissue margins move toward each o<strong>the</strong>r to un<strong>de</strong>rgo fusion. Tissue<br />

movement is driven by coordinated changes in cellular morphology,<br />

which require mechanical force. How is such force generated in a<br />

moving sheet of cells? A common feature observed both in normal<br />

morphogenesis and wounds is <strong>the</strong> formation of a supracellular<br />

actin/myosin cable which contracts and closes <strong>the</strong> gap in a purse<br />

string-like fashion.<br />

Currently, we are investigating <strong>the</strong> role of Tight Junctions (TJ) in<br />

<strong>the</strong>se processes. Our preliminary results revealed that <strong>the</strong> TJ protein<br />

tjp-3/ZO-3 is required for <strong>the</strong> formation of <strong>the</strong> actin/myosin cable.<br />

The impairment in cable formation leads to a <strong>de</strong>lay of <strong>the</strong> epiboly<br />

process and to a failure in wound closure. These observations<br />

implicate TJ components as novel players in epi<strong>the</strong>lial morphogenesis.<br />

22


How to preserve vision? Path to clinical application using human<br />

neural stem cells<br />

Alexandra Capela<br />

StemCells Inc.<br />

Age-related macular <strong>de</strong>generation (AMD) and retinitis pigmentosa<br />

(RP) are <strong>the</strong> two most prominent human retinal <strong>de</strong>generative<br />

disor<strong>de</strong>rs and combined account for <strong>the</strong> majority of vision loss in<br />

people over 40 years old.<br />

StemCells Inc. has <strong>de</strong>veloped a purified population of human central<br />

nervous system stem cells (hCNS-SCns) that are currently being<br />

tested in 3 clinical studies, Neuronal Ceroid Lipofuscinosis, a<br />

lysosomal storage disor<strong>de</strong>r, Pelizaeus-Merzbacher Disease, a<br />

dysmyelination disor<strong>de</strong>r and Spinal Cord injury. We now <strong>de</strong>monstrate<br />

that hCNS-SCns transplanted into <strong>the</strong> subretinal space of <strong>the</strong> Royal<br />

College of Surgeons (RCS) rat mo<strong>de</strong>l, a well-characterized animal<br />

mo<strong>de</strong>l of progressive photoreceptor <strong>de</strong>generation, rescue<br />

photoreceptors from <strong>de</strong>generation and preserve visual acuity and<br />

visual field sensitivity. These findings support clinical evaluation of<br />

hCNS-SCns as a neuroprotective strategy for select retinal<br />

<strong>de</strong>generative disor<strong>de</strong>rs.<br />

23


p53-targeted tumor <strong>the</strong>rapy: potential and limitations<br />

Melissa R. Junttila, Daniel Garcia, Anthony N. Karnezis, Francesc<br />

Madriles, Gerard I. Evan and Carla P. Martins(*)<br />

University of California San Francisco, Department of Pathology and<br />

Helen Diller Family Comprehensive Cancer Center, San Francisco,<br />

California 94143-0502, USA<br />

(*) Present address: Cancer Research UK Cambridge Research<br />

Institute, Li Ka Shing Centre, Robinson Way, Cambridge CB2 ORE, UK<br />

The high prevalence of specific mutations in tumors ma<strong>de</strong> targeted<br />

<strong>the</strong>rapies a new priority in drug <strong>de</strong>velopment. Inactivation of <strong>the</strong> p53<br />

pathway is a common feature in human tumors fostering <strong>the</strong><br />

attractive notion that p53-function restoration would constitute an<br />

effective and tumor-specific <strong>the</strong>rapeutic strategy. To establish <strong>the</strong><br />

<strong>the</strong>rapeutic potential of this approach we mo<strong>de</strong>led in vivo <strong>the</strong> impact<br />

of p53 restoration in tumors. We recently showed that p53<br />

restoration triggers dramatic tumor regression in a murine lymphoma<br />

mo<strong>de</strong>l, highlighting <strong>the</strong> <strong>the</strong>rapeutic potential of this strategy. To<br />

<strong>de</strong>termine its impact in epi<strong>the</strong>lial tumors we carried out a<br />

comprehensive analysis of <strong>the</strong> timing and mechanisms of p53<br />

activation during <strong>the</strong> evolution of lung tumors, <strong>the</strong> leading cause of<br />

cancer-related <strong>de</strong>ath worldwi<strong>de</strong>. Using a murine mo<strong>de</strong>l of non-small<br />

cell lung carcinoma we show that unexpectedly, p53 restoration failed<br />

to induce lung tumor clearance. Never<strong>the</strong>less we show that p53<br />

efficiently targets <strong>the</strong> most malignant tumor cells, but allows for <strong>the</strong><br />

less aggressive cell populations to survive. This tumor stage specific<br />

activation of p53 results from a selective increase in oncogenic<br />

signaling in malignant cells. The failure of low-level oncogenic stress<br />

to engage p53 reveals inherent limits in <strong>the</strong> capacity of p53 to<br />

restrain early tumor evolution and in <strong>the</strong> efficacy of <strong>the</strong>rapeutic p53<br />

restoration to eradicate cancers. Strategies aimed at improving <strong>the</strong><br />

<strong>the</strong>rapeutic impact of targeted <strong>the</strong>rapies for lung cancer treatment<br />

will also be discussed.<br />

24


The remarkable functional divergence of <strong>the</strong> Eukaryotic organellar<br />

Release Factors<br />

Isabel Duarte, Ramiro Morgado and Martijn Huynen<br />

ID and MH are affiliated with CMBI - NCMLS, Radboud University,<br />

Nijmegen, The Ne<strong>the</strong>rlands; RM is affiliated with Computational and<br />

Systems Biology - JIC, Norwich, UK<br />

Motivation: Organellar gene expression is far from un<strong>de</strong>rstood, with<br />

<strong>the</strong> genetic co<strong>de</strong> of <strong>the</strong> human mitochondrion being elucidated only in<br />

2010.<br />

Two codon-specific RFs are sufficient for <strong>de</strong> facto organellar<br />

translation termination: RF1 and RF2, but at least 3 o<strong>the</strong>r different<br />

subfamilies have been <strong>de</strong>scribed, whose exact function remains<br />

elusive. Our <strong>de</strong>tailed analysis sought to integrate different sources of<br />

information: localization prediction and experimental data available,<br />

phylogenetic distribution, organellar genetic co<strong>de</strong> and sequence<br />

structural features, to better <strong>de</strong>scribe this superfamily and predict<br />

unannotated proteins function.<br />

Materials and Methods: We used comparative genomics (Sequence<br />

Homology Searches, Multiple Sequence Alignment and Phylogeny)<br />

and Protein Structure Prediction to study <strong>the</strong> organellar RF<br />

superfamily in a carefully selected group of representative Eukaryotic<br />

organisms.<br />

Results and Discussion: This study briefly reports a new plant specific<br />

release factor subfamily, which has lost <strong>the</strong> 3 functional motifs<br />

experimentally <strong>de</strong>scribed as essential for bona-fi<strong>de</strong> release factor<br />

activity. Also, it predicts a plant RF2 subfamily, to be chloroplastic<br />

and not mitochondrial as previously annotated. And finally, we<br />

propose a possible re-invention of <strong>the</strong> standard genetic co<strong>de</strong> in <strong>the</strong><br />

green algae lineage.<br />

Conclusion: Here we analyze <strong>the</strong> evolution of organellar ribosomal<br />

Release Factors, uncovering a remarkable functional differentiation<br />

and showing its co-evolution with <strong>the</strong> organellar genetic co<strong>de</strong>. Also,<br />

our studies confirm <strong>the</strong> previously published evolutionary origin for<br />

<strong>the</strong> mitochondrial and plastidial RFs, in accordance with <strong>the</strong> currently<br />

undisputed endosymbiotic origin of <strong>the</strong>se organella. Finally, <strong>the</strong> motif<br />

shuffling and loss seen on each RF subfamily, hints at a significant<br />

functional divergence, hence proving that much is still to be<br />

uncovered about this process!<br />

25


ABSTRACTS FOR POSTER PRESENTATIONS<br />

Monday 27 December<br />

SESSION TWO<br />

26


Centrosome & Cilia Biogenesis & Evolution<br />

Mónica Bettencourt-Dias<br />

<strong>Instituto</strong> <strong>Gulbenkian</strong> <strong>de</strong> <strong>Ciência</strong><br />

Our research focuses on cell cycle progression and <strong>the</strong> cytoskeleton in<br />

normal <strong>de</strong>velopment and disease. We are particularly interested in<br />

<strong>the</strong> role played by microtubule organizing structures, such as <strong>the</strong><br />

centrosome, cilia and flagella. The centrosome is <strong>the</strong> major<br />

microtubule organizer in animal cells, and is very often abnormal in<br />

cancer. Cilia and flagella are cellular projections which are<br />

indispensable in a variety of cellular and <strong>de</strong>velopmental processes<br />

including cell motility, propagation of morphogenic signals and<br />

sensory reception. Despite <strong>the</strong>ir importance, we know very little<br />

about centrosome and cilia biogenesis or how <strong>the</strong>y may go awry in<br />

human disease. Our laboratory uses an integrated approach to study<br />

those questions: we combine studies in mo<strong>de</strong>l organisms with studies<br />

in human cells and bioinformatics to have an integrated view of this<br />

process. The fruit fly is an excellent organism to address those<br />

questions, since it combines possibilities of screening<br />

multiple genes with <strong>the</strong> ability to perform in-<strong>de</strong>pth regulation studies<br />

in <strong>the</strong> whole organism. As <strong>the</strong> regulatory mechanisms of <strong>the</strong> cell cycle<br />

and cytoskeleton have been highly conserved throughout evolution,<br />

we can extrapolate our findings to humans to test <strong>the</strong>ir relevance for<br />

human disease. An un<strong>de</strong>rstanding of <strong>the</strong> pathways involved in cell<br />

cycle and cytoskeleton can generate diagnostic and prognostic<br />

markers and hopefully provi<strong>de</strong> novel <strong>the</strong>rapeutic targets in human<br />

disease.<br />

28


Shared mechanisms during neural <strong>de</strong>velopment and tubulogenesis<br />

Sofia J. Araújo<br />

IBMB-CSIC, IRB Barcelona, Spain<br />

Tissue and organ morphogenesis in multicellular organisms relies on<br />

<strong>the</strong> precise coordination of multiple molecular pathways that control<br />

distinct cellular events. Cellular migration and pathfinding are two<br />

processes essential for morphogenesis. Their precise temporal and<br />

spatial coordination is crucial for cells to be able to establish<br />

connections over long distances. Correct control allows <strong>de</strong>velopment<br />

of multicelular organisms. Defects in control are associated with<br />

cancer <strong>de</strong>velopment.<br />

In Drosophila melanogaster neural and tracheal morphogenesis both<br />

involve cellular migration and pathfinding. To date, studies of<br />

Drosophila’s nervous and tracheal <strong>de</strong>velopment have been often<br />

performed separately, <strong>de</strong>spite <strong>the</strong> many common features between<br />

<strong>the</strong> two systems. This overlap is suggestive of shared mechanisms<br />

and cellular cooperation are likely to exist. We have been<br />

investigating <strong>the</strong> cooperative influence of tracheal cell migration and<br />

axonal guidance during <strong>de</strong>velopment. We have analysed a genetic<br />

screen for which mutants were isolated and characterised by <strong>the</strong>ir<br />

nervous system phenotypes and investigated <strong>the</strong>ir tracheal<br />

phenotypes. This approach is allowing us to i<strong>de</strong>ntify novel factors<br />

involved in <strong>the</strong> <strong>de</strong>velopment of both systems.<br />

29


Characterization and applications of a novel hemangioblast-specific<br />

transcriptional enhancer<br />

Ana Teresa Tavares (1,2) Vera Teixeira (2) and António Duarte<br />

(1,2)<br />

(1) CIISA, FMV, Lisboa, Portugal<br />

(2) IGC, Oeiras, Portugal<br />

During early vertebrate embryogenesis, <strong>the</strong>re is a close<br />

<strong>de</strong>velopmental relation between hematopoiesis and vasculogenesis.<br />

Primitive hematopoietic and endo<strong>the</strong>lial lineages both <strong>de</strong>rive from<br />

aggregates of meso<strong>de</strong>rmal cells that form <strong>the</strong> blood islands in <strong>the</strong><br />

extraembryonic yolk sac. This observation has led to <strong>the</strong> hypo<strong>the</strong>sis<br />

that both cell types originate from a common precursor known as <strong>the</strong><br />

hemangioblast. Chick Cerberus gene (cCer) co<strong>de</strong>s for a secreted<br />

factor expressed in <strong>the</strong> anterior mesendo<strong>de</strong>rm that gives rise to blood<br />

islands, among o<strong>the</strong>r tissues.<br />

During <strong>the</strong> study of cCer transcriptional regulation in chick embryos,<br />

we isolated a short cis-regulatory region that is able to drive reporter<br />

gene expression specifically in blood island precursor cells or<br />

hemangioblasts. We have been using this hemangioblast-specific<br />

reporter construct (Hb-eGFP) to characterize <strong>the</strong> gene expression<br />

profile of <strong>the</strong> chick hemangioblast and to track <strong>the</strong> origin and fate of<br />

hemangioblasts in living embryos. Here, we will present data on <strong>the</strong><br />

cell type-specificity of <strong>the</strong> hemangioblast enhancer as well as on <strong>the</strong><br />

dynamics of blood island morphogenesis and differentiation observed<br />

in Hb-eGFP-electroporated chick embryos.<br />

30


A genetic screen to i<strong>de</strong>ntify genes mediating ER stress induced retinal<br />

<strong>de</strong>generation in Drosophila<br />

Vanya Rasheva, Nadine Schweizer and Pedro Domingos<br />

<strong>Instituto</strong> <strong>de</strong> Tecnologia Química e Biológica (ITQB), Universida<strong>de</strong><br />

Nova <strong>de</strong> Lisboa, Av. Republica (EAN), 2780-157, Oeiras, Portugal<br />

(domingp@itqb.unl.pt)<br />

The endoplasmic reticulum (ER) is <strong>the</strong> cell organelle where secretory<br />

and membrane proteins are syn<strong>the</strong>sized and fol<strong>de</strong>d. Proteins that fail<br />

to fold properly (misfol<strong>de</strong>d proteins) accumulate in <strong>the</strong> ER, causing<br />

ER stress. The Unfol<strong>de</strong>d Protein Response (UPR) consists of several<br />

signalling pathways that have evolved to <strong>de</strong>tect <strong>the</strong> accumulation of<br />

misfol<strong>de</strong>d proteins in <strong>the</strong> ER and activate a cellular response that<br />

attempts to maintain homeostasis in <strong>the</strong> ER. If <strong>the</strong> protective<br />

mechanisms activated by <strong>the</strong> UPR are not sufficient to restore normal<br />

ER function cells die by apoptosis. How is <strong>the</strong> UPR regulated to<br />

change from a protective response to a pro-apoptotic one is still<br />

un<strong>de</strong>r question.<br />

We are performing a mosaic genetic screen aimed at i<strong>de</strong>ntifying<br />

suppressors of <strong>the</strong> retinal <strong>de</strong>generation phenotype caused by Xbp1<br />

overexpression in <strong>the</strong> eye. The i<strong>de</strong>ntification of genes regulated by<br />

Xbp1 will allow <strong>the</strong> characterization of <strong>the</strong> protective and apoptotic<br />

signalling pathways induced by ER stress.<br />

31


WDR62 in microcephaly and assymetric brain <strong>de</strong>velopment<br />

Ofelia P. <strong>de</strong> Carvalho, A<strong>de</strong>line K. Nicolas, Maryam Khurshid and C.<br />

Geoffrey Woods<br />

Cambridge Institute for Medical Research, University of Cambridge<br />

Autosomal recessive primary microcephaly (MCPH) is a disor<strong>de</strong>r of<br />

neuro<strong>de</strong>velopment resulting in a small brain. We i<strong>de</strong>ntified<br />

homozygous and frame-shifting <strong>de</strong>letions of WDR62 in seven<br />

consanguineous MCPH families. As well as being involved in MCPH,<br />

WDR62 mutations have been i<strong>de</strong>ntified in families with a wi<strong>de</strong><br />

spectrum of brain <strong>de</strong>velopment abnormalities including but not<br />

exclusive of microcephaly.<br />

In human cell lines WDR62 localizes to <strong>the</strong> spindle pole during<br />

mitosis, and in both mouse and human embryonic brain expression is<br />

found in neural precursors during mitosis. We attempt to elucidate<br />

<strong>the</strong> <strong>de</strong>velopmental mechanism(s) perturbed by mutations in this<br />

gene.<br />

32


Mutualistic Parasites - when hosts make use of <strong>the</strong>ir parasites and<br />

pathogens<br />

Francisco Dionisio<br />

Centro <strong>de</strong> Biologia Ambiental da Faculda<strong>de</strong> <strong>de</strong> Ciencias da<br />

universida<strong>de</strong> <strong>de</strong> Lisboa & <strong>Instituto</strong> <strong>Gulbenkian</strong> <strong>de</strong> Ciencia<br />

Parasites or pathogens and <strong>the</strong>ir hosts are expected to have<br />

conflicting interests, simply because parasite reproduction and<br />

transmission is done at <strong>the</strong> expense of <strong>the</strong> hosts fitness. However,<br />

this may not always be <strong>the</strong> case. Infected hosts can use <strong>the</strong>ir<br />

parasites/pathogens to harm o<strong>the</strong>rs, and increase <strong>the</strong>ir own relative<br />

fitness.<br />

33


The impact of antiretroviral treatment on <strong>the</strong> bur<strong>de</strong>n of invasive<br />

pneumococcal disease in South African children: A time series<br />

analysis<br />

Marta C Nunes, Shabir A and Madhi<br />

Respiratory and Meningeal Pathogens Research Unit, Department of<br />

Science and Technology/National Research Foundation: Vaccine<br />

Preventable Diseases, University of <strong>the</strong> Witwatersrand, South Africa<br />

Objective: HIV infection is a major risk factor for invasive<br />

pneumococcal disease (IPD). A national antiretroviral program was<br />

initiated in South Africa in 2004. This study evaluates <strong>the</strong> impact of<br />

<strong>the</strong> highly active antiretroviral (HAART) treatment program on <strong>the</strong><br />

bur<strong>de</strong>n of IPD among African children.<br />

Design: Retrospective analysis of laboratory-confirmed IPD among<br />

children un<strong>de</strong>r 18 years of age, from 2003 to 2008.<br />

Methods: The periods 2003-2004, 2005-2006 and 2007-2008 were<br />

<strong>de</strong>fined as <strong>the</strong> early-, intermediate- and established-HAART eras,<br />

respectively.<br />

Pneumococcal conjugate vaccine was not introduced into public<br />

immunization during this period.<br />

Results: 1,171 episo<strong>de</strong>s of IPD were i<strong>de</strong>ntified over <strong>the</strong> study-period.<br />

Among HIV-infected children un<strong>de</strong>r 18 years, <strong>the</strong> bur<strong>de</strong>n of IPD<br />

<strong>de</strong>creased by 50.8% (95% CI: 41.5; 58.7) and <strong>the</strong> inci<strong>de</strong>nce of IPDrelated<br />

mortality <strong>de</strong>clined by 65.2% (95% CI: 47.2; 77.0) from <strong>the</strong><br />

early- compared to <strong>the</strong> established-HAART era. This <strong>de</strong>cline in HIVinfected<br />

children was evi<strong>de</strong>nt for pneumococcal bacteremia and<br />

pneumococcal meningitis. In addition, similar reductions were<br />

observed for serotypes inclu<strong>de</strong>d in a 7-valent pneumococcal<br />

conjugate vaccine and non-vaccine serotypes. The bur<strong>de</strong>n of IPD<br />

remained unchanged in HIV-uninfected children un<strong>de</strong>r 18 years of<br />

age over <strong>the</strong>se periods. The risk of IPD, however, remained 42-fold<br />

greater in HIV-infected compared to HIV-uninfected children in <strong>the</strong><br />

established-HAART era.<br />

Conclusions: Although <strong>the</strong> HAART program has been associated with<br />

significant <strong>de</strong>clines in IPD morbidity and mortality, HIV-infected<br />

African children with access to HAART remain a high-risk group for<br />

IPD. These children should <strong>the</strong>refore be prioritized in <strong>the</strong> prevention<br />

of IPD.<br />

34


Role of Dll4-Notch signaling pathway in <strong>the</strong> angiogenesis of<br />

a<strong>the</strong>rosclerotic lesions and its potential <strong>the</strong>rapeutic aplication<br />

Vera Teixeira (1,2) Joana Gigante (1,2) Dusan Djokovic (1,2) and<br />

Ana Tavares (1,2)<br />

(1) CIISA, Faculda<strong>de</strong> <strong>de</strong> Medicina Veterinaria, Lisboa<br />

(2) <strong>Instituto</strong> <strong>Gulbenkian</strong> <strong>de</strong> Ciencia, Oeiras, Portugal<br />

A<strong>the</strong>rosclerosis is a <strong>de</strong>generative disease characterized by vascular<br />

inflammation, endo<strong>the</strong>lial dysfunction and progressive formation of<br />

intima plaques composed of lipids, calcium, and cellular <strong>de</strong>bris. As<br />

plaque <strong>de</strong>velops, new vessels arising from <strong>the</strong> adventitial vasa<br />

vasorum grow into <strong>the</strong> media and intima lesions. Evi<strong>de</strong>nces implicate<br />

<strong>the</strong>se neovessels in <strong>the</strong> regulation of plaque growth and stability.<br />

A<strong>the</strong>roma neovascularization inhibition has been proposed as an<br />

approach to restrict plaque growth and promote stabilization. In<strong>de</strong>ed,<br />

a promising antiangiogenic strategy for a<strong>the</strong>rosclerosis would<br />

<strong>de</strong>crease neovessel proliferation and induce functional maturation of<br />

<strong>the</strong> plaque microvessels. However, preliminary observations showing<br />

Dll4 expression increased in a<strong>the</strong>roma suggest also <strong>the</strong>rapeutical<br />

benefit in Dll4/Notch-inhibition. Therefore, we will investigate Dll4<br />

expression pattern during plaque <strong>de</strong>velopment, vasa vasorum levels<br />

in ApoE-/- mice and human patients, function of Dll4 in plaque<br />

angiogenesis and <strong>the</strong> <strong>the</strong>rapeutic potential of Dll4/Notch signaling<br />

modulators in <strong>the</strong> prevention and/or treatment of a<strong>the</strong>rosclerosis.<br />

Taken our current knowledge on <strong>the</strong> function of Dll4 in physiological<br />

and tumor angiogenesis we expect modulation of Dll4 levels to be an<br />

effective treatment of a<strong>the</strong>rosclerotic lesions. Our findings will<br />

contribute to unravel <strong>the</strong> molecular mechanisms of a<strong>the</strong>roma<br />

angiogenesis.<br />

35


Activity Depen<strong>de</strong>nt Cleavage of Neuroligin-1<br />

Rui Peixoto, Portia McCoy, Ben Philpot and Michael Ehlers<br />

Duke University, University of North Carolina<br />

Adhesive contact between pre- and postsynaptic neurons initiates<br />

synapse formation during brain <strong>de</strong>velopment and provi<strong>de</strong>s a natural<br />

means of trans-synaptic signaling. Numerous adhesion molecules and<br />

<strong>the</strong>ir role during synapse <strong>de</strong>velopment have been <strong>de</strong>scribed in <strong>de</strong>tail.<br />

However, once established, <strong>the</strong> mechanisms of adhesive disassembly<br />

and its function in regulating synaptic transmission have been<br />

uncertain. Here, we report that synaptic activity induces acute<br />

proteolytic cleavage of neuroligin-1 (NLG1), a postsynaptic adhesion<br />

molecule at glutamatergic synapses. NLG1 cleavage is triggered by<br />

NMDA receptor activation, requires Ca2+/calmodulin-<strong>de</strong>pen<strong>de</strong>nt<br />

protein kinase, and is mediated by proteolytic activity of matrix<br />

metalloprotease 9 (MMP9). Cleavage of NLG1 occurs in vivo, is<br />

regulated over brain <strong>de</strong>velopment, and causes rapid <strong>de</strong>stabilization of<br />

its presynaptic partner neurexin-1β (NRX1β). In turn, NLG1<br />

cleavage rapidly <strong>de</strong>presses synaptic transmission by abruptly<br />

reducing presynaptic release probability. Toge<strong>the</strong>r, our results <strong>de</strong>fine<br />

a novel mechanism for synapse remo<strong>de</strong>ling and trans-synaptic<br />

signaling during brain <strong>de</strong>velopment and plasticity.<br />

36


Ensembl Regulation: Functional Genomics @ Ensembl<br />

N. Johnson, D. Sobral, D. Keefe, B. Pritchard, S. Wil<strong>de</strong>r, E. Birney, P.<br />

Flicek and I. Dunham<br />

European Bioinformatics Institute (EMBL-EBI), Wellcome Trust<br />

Genome Campus, Hinxton, Cambridge, UK<br />

The Ensembl Functional Genomics (eFG) database and Application<br />

Program Interface (API) provi<strong>de</strong>s a platform for storage, analysis and<br />

visualisation of functional genomics data, within <strong>the</strong> centralised family<br />

of EnsEMBL databases. Wi<strong>de</strong>spread uptake of Nexte Generation<br />

Sequencing (NGS) based methods in projects including HEROIC,<br />

ENCODE and <strong>the</strong> Epigenomics Roadmap, as well as smaller<br />

hypo<strong>the</strong>sis-driven projects, has initiated a flood of data on<br />

transcription factor (TF) binding and chromatin state. The eFG<br />

databases incorporate 285 data sets from <strong>the</strong>se projects, primarily<br />

from ChIP-seq and DNase-seq assays across 9 human and 4 murine<br />

cell lines. This inclu<strong>de</strong>s <strong>the</strong> genomic binding sites for 56 TFs as well<br />

as <strong>the</strong> locations for 40 histones modifications. An additional 23 data<br />

sets i<strong>de</strong>ntifying sites of open chromatin or DNase 1 hypersensitivity<br />

are also now available. Data is incorporated via a standardised read<br />

mapping and peak calling pipeline to generate both normalised<br />

signal data and predicted enriched regions (“peaks” or “hits”) with<br />

peak summits. Both signal data and enriched regions are ma<strong>de</strong><br />

available in <strong>the</strong> Ensembl browser for visual comparison and<br />

interrogation.<br />

Higher-level annotations are also available in eFG, in <strong>the</strong> form of<br />

‘Regulatory Features’. The ‘Regulatory Build’ process uses all TF and<br />

open chromatin data across all cell types to establish locations that<br />

are potentially active in regulation (regulatory cores) in a multi-cell<br />

build step. Each cell-specific core region is <strong>the</strong>n exten<strong>de</strong>d, given that<br />

appropriate supporting data (e.g. histone markers) is present in that<br />

cell type. Regulatory Features are <strong>the</strong>n classified by consi<strong>de</strong>ring how<br />

different patterns of attributes are distributed in relation to various<br />

genomic features (e.g. promoter-associated, gene-associated). This<br />

process gives a set of annotated Regulatory Features for each cell<br />

type, as well as a set of core Regulatory Features presented in a<br />

multi-cell track.<br />

Ensembl is committed to immediate release of data and analysis into<br />

<strong>the</strong> public domain. As with all Ensembl software, eFG is available<br />

un<strong>de</strong>r an open source license from www.ensembl.org.<br />

37


Notch signalling regulation by cis-inhibitory effects<br />

Ulla-Maj Fiuza, Isabelle Becam,Thomas Klein, Marco Milán and<br />

Alfonso Martinez Arias<br />

Department of Genetics (University of Cambridge)<br />

Institute for Research and Biomedicine (Barcelona)<br />

Institute for Genetics (University of Cologne)<br />

Notch signalling is used iteratively during <strong>de</strong>velopment and also in<br />

<strong>the</strong> adult organism. There are several known diseases related with<br />

miss-regulation of <strong>the</strong> signalling activity, many causing severe<br />

<strong>de</strong>fects and some fatal. Un<strong>de</strong>rstanding <strong>the</strong> mechanisms involved in<br />

<strong>the</strong> regulation of this signalling pathway is of great importance for<br />

addressing how to tackle Notch related pathologies. In this work we<br />

present a study on <strong>the</strong> mechanisms of Notch signalling regulation<br />

mediated by interactions between <strong>the</strong> Notch receptor and its ligands<br />

Delta and Serrate. We start by fur<strong>the</strong>r characterizing a well<br />

established observation that Notch ligands besi<strong>de</strong>s having an<br />

activating role can have an inhibitory activity in a concentration<br />

<strong>de</strong>pen<strong>de</strong>nt manner. This function of ligands has been many times<br />

ascribed in <strong>the</strong> literature as a cell autonomous effect but no formal<br />

evi<strong>de</strong>nce for this had been previously produced. We fur<strong>the</strong>r present in<br />

vivo evi<strong>de</strong>nce suggesting that <strong>the</strong> Notch region involved in this<br />

inhibitory interaction is <strong>the</strong> Notch EGF-repeats 10-12 domain and cell<br />

culture data indicating that <strong>the</strong> ligand-inhibitory effect results from<br />

high levels of ligand inhibiting <strong>the</strong> ectodomain shedding of Notch.<br />

Ano<strong>the</strong>r type of inhibitory interactions is also explored that Notch can<br />

have a cis-inhibitory activity on Serrate signalling ability. The<br />

mechanism behind this regulatory interaction is i<strong>de</strong>ntified as an<br />

inhibitory regulation by Notch of <strong>the</strong> levels of Serrate. These crossregulatory<br />

interactions have paramount importance in establishing<br />

<strong>the</strong> state of signalling activity in different biological contexts for<br />

example: ligand cis-inhibition has been seen to modulate stem cell<br />

maintenance in epi<strong>the</strong>lial tissues and <strong>the</strong>re are now evi<strong>de</strong>nces<br />

towards evolution leading to protein specialization with some Delta<br />

family molecules only having an inhibitory activity. It will be<br />

interesting to see how this regulatory mechanisms act in multiple<br />

biological contexts.<br />

38


The SR45 plant-specific splicing factor is a negative regulator of sugar<br />

signaling during early growth in Arabidopsis<br />

Raquel Carvalho, Sofia Carvalho and Paula Duque<br />

<strong>Instituto</strong> <strong>Gulbenkian</strong> <strong>de</strong> <strong>Ciência</strong>, Oeiras, Portugal<br />

Being sessile, plants have <strong>de</strong>veloped unique adaptive strategies to<br />

cope with abiotic stress. These range from morphological<br />

modifications to physiological responses at <strong>the</strong> cellular level, but <strong>the</strong><br />

basis of <strong>the</strong> capacity for adaptation lies ultimately at <strong>the</strong> level of <strong>the</strong><br />

genome. Many plant genes un<strong>de</strong>rgo alternative splicing, which<br />

increases transcriptome and proteome complexity likely to be crucial<br />

in plant tolerance to adverse environmental conditions.<br />

Serine/arginine-rich (SR) proteins are known to modulate alternative<br />

splicing and o<strong>the</strong>r aspects of RNA metabolism, but <strong>the</strong>ir potential role<br />

in plant stress responses remains unexplored. Using reverse genetics,<br />

we found that SR45, a plant-specific Arabidopsis SR protein highly<br />

conserved throughout <strong>the</strong> plant kingdom with no orthologs in<br />

animals, is a novel player in glucose signaling during early seedling<br />

<strong>de</strong>velopment.<br />

The sr45-1 mutation confers hypersensitivity to glucose, with mutant<br />

seedlings grown in <strong>the</strong> presence of <strong>the</strong> sugar displaying impaired<br />

cotyledon <strong>de</strong>velopment and hypocotyl elongation, as well as altered<br />

glucose-responsive gene expression. The mo<strong>de</strong> of action of SR45<br />

involves downregulation of <strong>the</strong> abscisic acid (ABA) stress signaling<br />

pathway, via repression of both glucose-induced ABA endogenous<br />

accumulation and ABA biosyn<strong>the</strong>sis and signaling gene expression.<br />

Epistasis analyses suggest a mechanism in<strong>de</strong>pen<strong>de</strong>nt of <strong>the</strong><br />

hexokinase 1 (HXK1) sugar sensor, and preliminary results indicate<br />

that SR45 modulates <strong>the</strong> levels of KIN10, a protein kinase involved in<br />

sensing/signaling of stress-associated energy <strong>de</strong>privation.<br />

39


When knowledge is <strong>the</strong> product – what is customer value?<br />

A study of market orientation in a research not-for-profit<br />

organisation.<br />

Greta Martins<br />

MBA dissertation <strong>the</strong>sis, University of Leicester, UK<br />

The rationale of market orientation (MO) is based on Porter (1985)’s<br />

five-competitive force mo<strong>de</strong>l for industries in <strong>the</strong> creation of value by<br />

raising entrance barriers through engen<strong>de</strong>ring and sustaining<br />

competitive advantage. The marketing philosophy holds that a way to<br />

do this is by satisfying customer needs and wants more effectively<br />

than competitors. MO is conceptualised on profitability maximisation<br />

through <strong>de</strong>livering superior customer value to competitors by<br />

harnessing resources on an organisation-wi<strong>de</strong> basis, hence literature<br />

advocates <strong>the</strong> existence of an MO culture in an organisation.<br />

Rapidly changing environments have forced not-for-profits (NFP)s to<br />

adopt businesses practices such as MO for sustainability and growth.<br />

In<strong>de</strong>ed studies show that NFPs favour stronger links with<br />

organisational performance than businesses in <strong>de</strong>veloping an MO<br />

strategy. However, studies reveal that due to <strong>the</strong> higher social<br />

context of <strong>the</strong> NFP environment, as opposed to mandatory initiatives,<br />

it is more effective to adopt market activities into <strong>the</strong> culture so as to<br />

<strong>de</strong>velop a market orientation culture. This study takes a counter<br />

view that when a NFP is knowledge-based, MO is <strong>de</strong>veloped through<br />

organisational culture. Therefore <strong>the</strong> nature of <strong>the</strong> NFP activity<br />

influences <strong>the</strong> <strong>de</strong>velopment of MO.<br />

A small NFP scientific research institution (<strong>the</strong> <strong>Instituto</strong> <strong>Gulbenkian</strong> <strong>de</strong><br />

<strong>Ciência</strong>) was selected as empirical context. Semi-structured<br />

interviews were conducted to gain insight into <strong>the</strong> <strong>de</strong>velopment of MO<br />

through <strong>the</strong> relationship of <strong>the</strong> scientists with a key stakehol<strong>de</strong>r<br />

group – <strong>the</strong> PhD stu<strong>de</strong>nts. In consi<strong>de</strong>ring <strong>the</strong> stu<strong>de</strong>nts as customers<br />

what were <strong>the</strong> perceptions of customer value?<br />

40


ABSTRACTS FOR ORAL PRESENTATIONS<br />

Monday 27 December<br />

SESSION THREE<br />

42


Host response mechanisms to malaria liver infection: The role of<br />

ubiquitin-proteasome pathway<br />

Zuzarte-Luís (1) N. Nagaraj (2) C. Carret (1) M. Mann (2) and M.<br />

Mota (1)<br />

(1) <strong>Instituto</strong> <strong>de</strong> Medicina Molecular, Portugal<br />

(2) Max Planck Institute for Biochemistry, Martinsried, Germany<br />

Malaria is caused by Plasmodium, an apicomplexan parasite<br />

transmitted through <strong>the</strong> bite of an infected female Anopheles<br />

mosquito. The infection starts when <strong>the</strong> mosquito injects Plasmodium<br />

sporozoites into <strong>the</strong> skin of <strong>the</strong> vertebrate host. After traversing <strong>the</strong><br />

<strong>de</strong>rmis <strong>the</strong> parasites enter <strong>the</strong> circulatory system and travel to <strong>the</strong><br />

liver where <strong>the</strong>y un<strong>de</strong>rgo major transformations and commence a<br />

period of remarkable schizogynous division into an exoerythrocytic<br />

form (EEF). This asymptomatic <strong>de</strong>velopment step will eventually lead<br />

to <strong>the</strong> release of thousands of mature merozoites into <strong>the</strong><br />

bloodstream, initiating <strong>the</strong> symptomatic stage of <strong>the</strong> disease.<br />

In humans, <strong>the</strong> hepatic stage of <strong>the</strong> infection lasts 6-10 days during<br />

which <strong>the</strong> number of parasites expands enormously, up to 40000<br />

fold. Surprisingly, such an active process of parasitic <strong>de</strong>velopment<br />

progresses “invisible” to <strong>the</strong> host’s immune system. As a<br />

consequence, immunity to <strong>the</strong> hepatic stage is not acquired naturally<br />

and hence, populations in malaria en<strong>de</strong>mic areas lack protective<br />

immunity, even after repeated exposures to <strong>the</strong> parasite.<br />

Un<strong>de</strong>rstanding how <strong>the</strong> <strong>de</strong>veloping parasite overcomes <strong>the</strong> host<br />

immune system guaranteeing its own survival will constitute a major<br />

breakthrough, possibly leading to <strong>the</strong> <strong>de</strong>velopment of an anti-malarial<br />

vaccine.<br />

44


Herpesviral Intrahost Spread<br />

Miguel Gaspar and Philip Stevenson<br />

University of Cambridge<br />

Herpesviruses are important human pathogens able to establish a<br />

life-long latent infection insi<strong>de</strong> host cells hid<strong>de</strong>n from <strong>the</strong> immune<br />

system. Murid Herpesvirus 4 (MuHV4) is a gamma-herpesvirus that<br />

infects mice and is commonly used as an in vivo mo<strong>de</strong>l of <strong>the</strong> human<br />

gamma-herpesviruses EBV and KSHV as <strong>the</strong> characteristics of <strong>the</strong>ir<br />

infections are similar. MuHV4 enters <strong>the</strong> organism via <strong>the</strong> nose,<br />

probably infecting an epi<strong>the</strong>lial cell, and establishes latency insi<strong>de</strong> B<br />

lymphocytes in <strong>the</strong> lymph no<strong>de</strong>s and spleen. However, it is unknown<br />

how <strong>the</strong> virus reaches <strong>the</strong> lymph no<strong>de</strong>s and spleen and how it infects<br />

its main cellular target, B cells as <strong>the</strong>se cells are resistant to infection<br />

in vitro. We are currently testing <strong>the</strong> hypo<strong>the</strong>sis that MuHV4 uses<br />

<strong>de</strong>ndritic cells (DCs) as Trojan horses to reach <strong>the</strong> lymph no<strong>de</strong>s and<br />

to infect B cells by cell-to-cell transmission. We have already show<br />

that DCs are susceptible to MuHV4 infection in vivo and in vitro and<br />

that latent in vitro infection results in a dramatic rearrangement of<br />

<strong>the</strong> actin cytoskeleton and o<strong>the</strong>r structural changes associated with<br />

increased mobility.<br />

We are currently using mice expressing Cre recombinase in DCs in<br />

combination with viruses where loxP sites flank essential genes and<br />

fluorescent markers in or<strong>de</strong>r to <strong>de</strong>monstrate <strong>the</strong> importance of DCs in<br />

virus dissemination insi<strong>de</strong> <strong>the</strong> host. The i<strong>de</strong>ntification of a specific cell<br />

type responsible for <strong>the</strong> transport of <strong>the</strong> virus from <strong>the</strong> site of lytic<br />

replication to <strong>the</strong> site of latency can yield novel <strong>the</strong>rapeutic targets to<br />

prevent latency establishment.<br />

45


Coupling RNA processing and chromatin modification in S.cerevisiae<br />

Luis Soares and Steve Buratowski<br />

BCMP, Harvard Medical School, Boston MA<br />

Eukaryotic gene expression inclu<strong>de</strong>s several steps that must be<br />

coordinated to allow organisms to survive, <strong>de</strong>velop and adapt to<br />

environmental changes. The first step in gene expression involves <strong>the</strong><br />

transcription of genes with <strong>the</strong> production of mRNAs that are later<br />

translated into proteins. Between <strong>the</strong> initial and final events of gene<br />

expression <strong>the</strong> mRNA un<strong>de</strong>rgoes several processing steps that affect<br />

its ability to be translated.<br />

It has been shown that transcription and RNA processing are not<br />

temporarily separated and must be connected in or<strong>de</strong>r to achieve<br />

correct gene expression. Pre-mRNA processing events such as<br />

splicing and poly-a<strong>de</strong>nylation have been shown to be <strong>de</strong>pen<strong>de</strong>nt on<br />

<strong>the</strong> modulation of <strong>the</strong> activity of RNA polymerase II and on <strong>the</strong><br />

modifications of <strong>the</strong> CTD of its largest subunit.<br />

Using S.cerevisiae as a mo<strong>de</strong>l system we study <strong>the</strong> recruitment of<br />

processing factors to transcribing genes and how this recruitment<br />

correlates with chromatin modifications. Our results revealed that<br />

modulation of particular histone modifications in yeast affect RNA<br />

processing efficiency by modifying <strong>the</strong> cotrancriptional recruitment of<br />

factors. We i<strong>de</strong>ntified a novel pathway by which <strong>the</strong> COMPASS<br />

complex (responsible for H3K4 methylation) affects <strong>the</strong> recruitment<br />

of splicing and poly-a<strong>de</strong>nylation factors during transcription. The<br />

mechanism of this effect seems to be <strong>de</strong>pen<strong>de</strong>nt both on <strong>the</strong> direct<br />

recruitment of factors by this complex and on general effects that<br />

H3K4 methylation has on <strong>the</strong> activity of RNA polymerase II.<br />

46


Patterned cell-adhesion during morphogenesis<br />

Ana Mateus and Alfonso Martinez Arias<br />

Affiliations for Abstract - Department of Genetics, Cambridge<br />

University, UK<br />

Cell shape changes within epi<strong>the</strong>lia require <strong>the</strong> regulation of adhesive<br />

molecules that maintain tissue integrity. How remo<strong>de</strong>lling of cell<br />

contacts and maintenance of tissue integrity is achieved is a<br />

fundamental question in morphogenesis. Cadherins are<br />

transmembrane proteins that mediate cell-cell adhesion and, in<br />

epi<strong>the</strong>lia, localise at <strong>the</strong> adherens junctions (AJs). Analysis of<br />

Drosophila E-Cadherin mutant embryos suggests that DE-Cadherin<br />

regulation during Dorsal Closure (DC) relies mainly on posttranscriptional<br />

regulation. In this study, we <strong>de</strong>veloped an assay to<br />

assess <strong>the</strong> dynamics of DE-Cadherin. This assay revealed that native<br />

DE-Cadherin has different antibody binding properties <strong>de</strong>pending on<br />

its location and <strong>the</strong> antibody used, which has never been observed in<br />

fixed DE-Cadherin in Drosophila embryos. A monoclonal antibody<br />

against <strong>the</strong> extracellular domain of DE-Cadherin labels amnioserosa<br />

(AS) and dorsal-most epi<strong>de</strong>rmal (DME) cells, but not <strong>the</strong> lateral<br />

epi<strong>de</strong>rmal cells, which contrasts with a polyclonal antibody that labels<br />

all epi<strong>de</strong>rmal cells. These differences could result from different<br />

conformation/organization of <strong>the</strong> Cadherins that confer different<br />

adhesive strengths. Regional modulation of adhesion could represent<br />

a general mechanism in morphogenesis, ensuring <strong>the</strong> maintenance of<br />

adhesion in key regions of <strong>the</strong> tissue subjected to more tension.<br />

47


Control of tissue growth and homeostasis by <strong>the</strong> integrated activities<br />

of Hippo signaling and Drosophila Myc<br />

Neto-Silva RM (1) (2) (*) and Johnston LA (2)<br />

(1) <strong>Gulbenkian</strong> PhD Programme in Biomedicine, <strong>Instituto</strong> <strong>Gulbenkian</strong><br />

<strong>de</strong> Ciencia, Rua da Quinta Gran<strong>de</strong>, 6, P-2780-156 Oeiras, Portugal<br />

(2) Department of Genetics and Development, Columbia University<br />

Medical Center, 701 West 168th Street, New York, NY 10032, USA<br />

(*) Present address - Champalimaud Neuroscience Programme at<br />

<strong>Instituto</strong> <strong>Gulbenkian</strong> <strong>de</strong> Ciencia, Rua da Quinta Gran<strong>de</strong>, 6, P-2780-<br />

156 Oeiras, Portugal<br />

An un<strong>de</strong>rstanding of how animal size is controlled requires knowledge<br />

of how positive and negative growth regulatory signals are balanced<br />

and integrated within cells. I will present data showing that <strong>the</strong><br />

activities of <strong>the</strong> conserved growth-promoting transcription factor Myc<br />

and <strong>the</strong> tumor-suppressing Hippo pathway are co<strong>de</strong>pen<strong>de</strong>nt during<br />

growth of Drosophila imaginal discs. We find that Yorkie (Yki), <strong>the</strong><br />

Drosophila homolog of <strong>the</strong> Hippo pathway transducer, Yap, regulates<br />

<strong>the</strong> transcription of Myc, and that Myc functions as a critical cellular<br />

growth effector of <strong>the</strong> pathway. We <strong>de</strong>monstrate that in turn, Myc<br />

regulates <strong>the</strong> expression of Yki as a function of its own cellular level,<br />

such that high levels of Myc repress Yki expression through both<br />

transcriptional and posttranscriptional mechanisms. We propose that<br />

<strong>the</strong> co<strong>de</strong>pen<strong>de</strong>nt regulatory relationship functionally coordinates <strong>the</strong><br />

cellular activities of Yki and Myc, and provi<strong>de</strong>s a mechanism of growth<br />

control that regulates organ size and has potential implications for<br />

cancer.<br />

48


Slitrk5 a new neuronal protein implicated in obsessive-compulsivelike<br />

behaviors in mice<br />

Proenca CC, Shmelkov SV, Ninan I, Rafii S and Lee FS<br />

Weill Cornell Medical College, New York<br />

<strong>Instituto</strong> <strong>Gulbenkian</strong> <strong>de</strong> Ciencia, Oeiras<br />

New York University Langone Medical Center, New York,<br />

Obsessive-compulsive disor<strong>de</strong>r (OCD) is a common psychiatric<br />

disor<strong>de</strong>r <strong>de</strong>fined by <strong>the</strong> presence of obsessive thoughts and repetitive<br />

compulsive actions, and often encompasses anxiety and <strong>de</strong>pressive<br />

symptoms as well. Recently, <strong>the</strong> cortico-striatal circuitry has been<br />

implicated in <strong>the</strong> pathogenesis of OCD. However, <strong>the</strong> etiology and<br />

pathophysiology of OCD is still not un<strong>de</strong>rstood and <strong>the</strong> molecular<br />

basis is not known. Several studies indicate that pathogenesis of OCD<br />

has a genetic component. Here we <strong>de</strong>monstrate that loss of a<br />

neuron-specific transmembrane protein, Slitrk5, leads to OCD<br />

behaviors in mice, which manifests in excessive self-grooming and<br />

anxiety, and is alleviated by <strong>the</strong> selective serotonin reuptake<br />

inhibitor, fluoxetine. slitrk5-/- mice display selective abnormalities in<br />

striatal anatomy and cell morphology, as well as alteration in striatal<br />

glutamate receptor composition, which contribute to <strong>de</strong>ficient corticostriatal<br />

neurotransmission in adult mice. Thus, our studies i<strong>de</strong>ntify<br />

Slitrk5 as an essential molecule at <strong>the</strong> cortical-striatal synapses, and<br />

provi<strong>de</strong> a novel mo<strong>de</strong>l to screen for pharmacological agents for <strong>the</strong><br />

treatment of OCD.<br />

49


Forced NF-kappaB in T cells leads to Tumor Rejection<br />

Cesar Evaristo (1) Thomas Gajewski (2) and Maria-Luisa Alegre (1)<br />

(1) Department of Medicine<br />

(2) Department of Pathology, University of Chicago, Chicago, IL<br />

NF-kappaB activity has been reported to be reduced in T cells from<br />

tumor-bearing hosts. Our previous results indicate that reduced NFkappaB<br />

activation results in impaired survival of T cells, <strong>de</strong>creased<br />

Th1 and Th17 differentiation and increased iTreg differentiation. Mice<br />

with reduced T cell-NF-kappaB activity fail to reject cardiac and<br />

pancreatic islet allografts in <strong>the</strong> absence of any pharmacological<br />

treatment. We hypo<strong>the</strong>size that forced activation of NF-kappaB in T<br />

cells should have <strong>the</strong> opposite effect and promote T cell survival,<br />

facilitate Th1/Th17 differentiation and prevent iTreg differentiation,<br />

which would be beneficial to reject tumors. We generated mice with<br />

constitutively active IKKbeta in T cells (henceforth CA-IKKbeta mice).<br />

Ectopic expression of CA-IKKbeta resulted in phosphorylation of NFkappaB.<br />

Transgene expression was limited to CD4+, CD8+ and NKT<br />

cells and T cells showed increased NF-kappaB activation and nuclear<br />

translocation. T cell numbers were comparable to littermate controls,<br />

but CA-IKKbeta mice had fewer Tregs and increased frequency of<br />

activated T cells that produced IFNgamma upon re-stimulation. When<br />

B16-SIY melanoma cells were injected subcutaneously, tumors grew<br />

progressively in control littermates, whereas <strong>the</strong>y were rejected by<br />

mice expressing CA-IKKbeta in T cells. Fur<strong>the</strong>rmore, IKKbeta-CA<br />

expressing CD4+ and CD8+ T cells were necessary and sufficient for<br />

tumor control. Our results <strong>de</strong>monstrate NF-kappaB to be at <strong>the</strong> crossroads<br />

of major T cell fate <strong>de</strong>cisions that should uniquely synergize for<br />

control of tumor growth.<br />

50


Proteomics of Isolated Chromatin Segments<br />

José Antão (1) James M. Mason(2) Jérôme Ájardin (3) and Robert<br />

E. Kingston (1)<br />

(1) Department of Molecular Biology, Massachusetts General Hospital,<br />

Boston, USA<br />

(2)NIEHS, Research Triangle Park, NC, USA<br />

(3)Genetique Humaine, CNRS, Montpellier, France<br />

The regulation of any genomic locus is done, in large measure, by <strong>the</strong><br />

complement of proteins that bind to it in a given cellular context.<br />

Even though <strong>the</strong>re are some powerful tools for looking at protein<br />

localization in <strong>the</strong> genome through a candidate-based approach, an<br />

unbiased method for i<strong>de</strong>ntifying all proteins bound to a specific DNA<br />

element at a given time has been lacking. We have <strong>de</strong>veloped a<br />

method that uses a DNA/LNA-based oligonucleoti<strong>de</strong> probe to target<br />

and specifically purify genomic segments in <strong>the</strong>ir chromatin<br />

environment, and <strong>de</strong>termine <strong>the</strong>ir protein composition. Using this<br />

method, we have i<strong>de</strong>ntified proteins that bind to <strong>the</strong> Drosophila<br />

Telomeric-Associated Sequence (TAS) repeats and, through a genetic<br />

screen, we have confirmed <strong>the</strong> involvement of one of <strong>the</strong>se proteins<br />

in <strong>the</strong> control of Telomeric Position Effect (TPE), a gene silencing<br />

mechanism mediated by <strong>the</strong> TAS repeats.<br />

51


A genome-wi<strong>de</strong> RNAi screen for Neuroblast cell cycle exit in<br />

Drosophila<br />

Catarina C. Homem and Juergen A. Knoblich<br />

Institute of Molecular Biotechnology of <strong>the</strong> Austrian Aca<strong>de</strong>my of<br />

Sciences (IMBA)<br />

During <strong>de</strong>velopment, Drosophila neural stem cells, <strong>the</strong> Neuroblasts<br />

(Nbs), divi<strong>de</strong> asymmetrically to self-renew and to generate a<br />

differentiated Ganglion Mo<strong>the</strong>r Cell (GMC). The GMC divi<strong>de</strong>s once<br />

more to generate two post-mitotic neurons or glia. Drosophila Nbs<br />

un<strong>de</strong>rgo multiple rounds of divisions generating hundreds of neurons,<br />

which make up <strong>the</strong> nervous system of <strong>the</strong> fly. Drosophila Nbs divi<strong>de</strong><br />

throughout <strong>de</strong>velopment, but stop dividing and disappear just before<br />

entering adult stages. To maintain <strong>the</strong> correct number and type of<br />

neurons, it is essential to precisely regulate <strong>the</strong> time at which<br />

neurogenesis ceases. Although several factors influencing neural<br />

proliferation have been i<strong>de</strong>ntified, <strong>the</strong> un<strong>de</strong>rlying molecular<br />

mechanism scheduling <strong>the</strong> end of progenitor divisions remains<br />

enigmatic. Tight control of <strong>the</strong> number of self-renewing and<br />

differentiating daughter cells is also crucial to prevent uncontrolled<br />

proliferation and tumor formation.<br />

To i<strong>de</strong>ntify novel genes regulating stem cell proliferation and division<br />

termination we are carrying out a genome wi<strong>de</strong> in vivo RNAi screen<br />

using Nbs as a mo<strong>de</strong>l. In our assay we co-express Luciferase and<br />

RNA hairpins specifically in a subset of Nbs and <strong>the</strong>ir respective<br />

progeny. We <strong>the</strong>n measure luminescence amounts in <strong>the</strong> adult head<br />

to assess Nb number and lineage sizes.<br />

Up to now we have screened a total of 7500 RNAi lines targeting<br />

53.6% of <strong>the</strong> protein coding genes in <strong>the</strong> Drosophila genome. We<br />

have i<strong>de</strong>ntified significant increases in luminescence in 6.8% of <strong>the</strong><br />

RNAi lines screened, corresponding to 402 genes. In this group, we<br />

expect to find several classes of genes involved in <strong>the</strong> regulation of<br />

Nb size, life-span and proliferation.<br />

Consistent with our hypo<strong>the</strong>sis, among <strong>the</strong>se we find Brat, Numb and<br />

Miranda, known to cause Nb number increase and tumor formation.<br />

In a secondary analysis by immunofluorescence we have, so far,<br />

i<strong>de</strong>ntified three previously uncharacterized potential tumor<br />

suppressors and two new genes potentially involved in Nb life-span<br />

regulation.<br />

52


A bit of T cell immunology, or playing a different type of CD<br />

Bruno Silva-Santos<br />

Insituto <strong>de</strong> Medicina Molecular, Lisboa<br />

For an immunologist, fellow non-immunologist scientists must be<br />

often treated as “lay audience” due to heavy jargon that inclu<strong>de</strong>s<br />

many CD numbers (CD3, CD127…) and an increasing amount of Th<br />

subsets (from Th1 to Th22 or more…). While keeping that in mind, I<br />

will try to summarize <strong>the</strong> research <strong>de</strong>veloped in my lab over <strong>the</strong> past<br />

4 years. It will be a rapid journey on T cell differentiation and T cell<br />

responses to infectious microrganisms and tumours. Instead of <strong>the</strong><br />

most common CD4+ or CD8+ lymphocytes, we will mostly discuss<br />

<strong>the</strong> unconventional gamma-<strong>de</strong>lta T cell subset. I leave you <strong>the</strong> three<br />

take home messages: my favourite CD number is 27 because CD27<br />

plays key roles in thymic <strong>de</strong>velopment and peripheral expansion of<br />

gamma-<strong>de</strong>lta T cells; ULBP1 is <strong>the</strong> critical tumour antigen for gamma<strong>de</strong>lta<br />

T cell recognition of haematological tumours; and we are now<br />

studying <strong>the</strong> molecular (epigenetic-to-transcriptional-to-posttranscriptional)<br />

mechanisms of Th1 and Th17 differentiation in vivo…<br />

Well, I will try to be clearer during <strong>the</strong> talk…<br />

53


Quiescent neuroblasts are reactivated via TOR and paracrine Insulin<br />

relays in Drosophila<br />

Rita Sousa-Nunes, Lih Ling Yee and Alex P. Gould<br />

Division of Developmental Neurobiology, Medical Research Council<br />

National Institute for Medical Research, The Ridgeway, Mill Hill,<br />

London NW7 1AA, UK<br />

Many stem, progenitor and cancer cells un<strong>de</strong>rgo periods of mitotic<br />

quiescence from which <strong>the</strong>y can be reactivated. The signals triggering<br />

entry into and exit from this reversible dormant state are not well<br />

un<strong>de</strong>rstood. Multipotent self-renewing progenitors in <strong>the</strong> <strong>de</strong>veloping<br />

Drosophila central nervous system (CNS), termed neuroblasts,<br />

un<strong>de</strong>rgo quiescence in a stereotypical spatiotemporal pattern. Entry<br />

into quiescence is regulated by Hox proteins and an internal<br />

neuroblast timer. Exit from quiescence (reactivation) is subject to a<br />

nutritional checkpoint requiring dietary amino acids. Organ co-culture<br />

experiments also implicate an uni<strong>de</strong>ntified signal from an<br />

adipose/hepatic-like tissue called fat body. However, it has been<br />

unclear how <strong>the</strong>se CNS-extrinsic nutritional cues are transmitted to<br />

quiescent neuroblasts. Here, we provi<strong>de</strong> in vivo evi<strong>de</strong>nce that<br />

neuroblasts are able to sense amino acids indirectly, via a tissue-totissue<br />

relay: fat body and CNS glia, neurons and neuroblasts. We find<br />

that a signal secreted by <strong>the</strong> fat body, <strong>de</strong>pen<strong>de</strong>nt upon amino-acid<br />

and Target-of-Rapamycin (TOR) signalling, is required for neuroblasts<br />

to exit quiescence. We also <strong>de</strong>monstrate that Insulin-like Pepti<strong>de</strong>s<br />

(Ilps), produced by CNS glia/neurons in a nutrient-<strong>de</strong>pen<strong>de</strong>nt<br />

manner, are necessary and sufficient for timely neuroblast<br />

reactivation but do not regulate overall larval size. Conversely,<br />

systemic Ilps secreted into <strong>the</strong> hemolymph by median neurosecretory<br />

cells (mNSCs) regulate organismal size but do not reactivate<br />

neuroblasts. Drosophila thus contains two segregated Ilp pools, one<br />

regulates neuroblast proliferation within <strong>the</strong> CNS and <strong>the</strong> o<strong>the</strong>r<br />

controls tissue growth systemically. Toge<strong>the</strong>r, our findings support a<br />

tissue relay mo<strong>de</strong>l in which amino-acid sensing by <strong>the</strong> fat body<br />

stimulates Insulin signalling from glia/neurons, triggering<br />

Phosphatidylinositol 3-Kinase (PI3K)/TOR activation in neuroblasts, in<br />

turn leading to cell cycle re-entry. This mechanism links syst<br />

emic and tissue-restricted signals to neural proliferation and, more<br />

generally, highlights that dietary nutrients and remote organs are key<br />

regulators of transitions in stem-cell behaviour.<br />

54


CISA Project – Developing a Health Research Center in Angola<br />

Susana Vaz Nery<br />

CISA Project<br />

The “CISA Project”, a partnership between <strong>the</strong> Angolan Ministry of<br />

Health, <strong>the</strong> Bengo Provincial Government, <strong>the</strong> Portuguese<br />

Development Aid Institute and <strong>the</strong> <strong>Calouste</strong> <strong>Gulbenkian</strong> Foundation,<br />

aims to <strong>de</strong>velop a Health Research Centre in Angola (CISA), located<br />

in <strong>the</strong> city of Caxito, Dan<strong>de</strong>´s municipality, Bengo´s Province.<br />

The “CISA Project” promotes epi<strong>de</strong>miological and clinical research on<br />

<strong>the</strong> most prevalent or relevant diseases in Angola, such as malaria,<br />

tuberculosis and neglected tropical diseases (including<br />

schistosomiasis and intestinal parasitoses).<br />

The <strong>Calouste</strong> <strong>Gulbenkian</strong> Foundation leads <strong>the</strong> CISA Project<br />

management, whereas in Caxito research activity is implemented by<br />

a team of more than 60 people.<br />

In 2009 a Demographic Surveillance System (DSS) has been<br />

established, with <strong>the</strong> aim of characterizing <strong>the</strong> size and dynamics of<br />

Dan<strong>de</strong>´s population and its geographical distribution, thus providing<br />

background information for epi<strong>de</strong>miological studies. The initial census<br />

of <strong>the</strong> DSS-Dan<strong>de</strong> was completed in April 2010, covering a population<br />

of more than 60,000 resi<strong>de</strong>nts.<br />

A baseline prevalence survey on malaria, schistosomiasis, intestinal<br />

parasitoses, anaemia and malnutrition in <strong>the</strong> DSS study area is being<br />

completed, and it will sample approximately 3000 people. In parallel<br />

to this study an ethnobotanic baseline survey was also implemented.<br />

O<strong>the</strong>r scientific activities initiated in 2010 inclu<strong>de</strong>: 1) a pilot to<br />

establish a verbal autopsy system in or<strong>de</strong>r to <strong>de</strong>termine <strong>the</strong> main<br />

causes of <strong>de</strong>aths that happen in <strong>the</strong> community; and 2) a pediatrics<br />

clinical surveillance system that will provi<strong>de</strong> a platform for clinical<br />

research studies besi<strong>de</strong>s improving <strong>the</strong> quality of documentation and<br />

care at <strong>the</strong> hospital.<br />

55


Adaptation in Escherichia coli<br />

Isabel Gordo<br />

<strong>Instituto</strong> <strong>Gulbenkian</strong> <strong>de</strong> Ciencia<br />

Adaptation involves changes in <strong>the</strong> genotype, which will <strong>the</strong>n have<br />

phenotypic consequences that increase <strong>the</strong> ability of survival and<br />

reproduction of organisms in a given environment. The problem is<br />

that organisms adapt through mutations that are random with<br />

respect to <strong>the</strong>ir needs. In or<strong>de</strong>r to un<strong>de</strong>rstand <strong>the</strong> process of<br />

adaptation we are performing experimental evolution. We are<br />

studying <strong>the</strong> rate and effects of adaptive mutations in populations of<br />

Escherichia coli, adapting to different environments. We interpret our<br />

results on <strong>the</strong> fitness effects of new adaptive mutations in <strong>the</strong> light of<br />

Fisher's geometrical mo<strong>de</strong>l and are <strong>de</strong>veloping <strong>the</strong>oretical extensions<br />

of this mo<strong>de</strong>l.<br />

56


Membrane trafficking in synaptic <strong>de</strong>velopment<br />

Rita O. Teodoro and Thomas L. Schwarz<br />

F.M. Kirby Neurobiology Center, Children’s Hospital Boston and<br />

Department of Neurobiology, Harvard Medical School<br />

Neurons are specialized cells that can extend over great distances,<br />

enabling <strong>the</strong> complex networking of <strong>the</strong> nervous system. Like all<br />

o<strong>the</strong>r eukaryotic cells, it is essential for neurons to have tight spatial<br />

control of exocytosis in or<strong>de</strong>r to form and maintain specialized<br />

domains within <strong>the</strong> cell. Membrane trafficking is emerging as a key<br />

aspect of neuronal <strong>de</strong>velopment and function. The exocyst is a<br />

protein complex linked to membrane traffic and one way it is<br />

regulated is by its interaction with several small GTPases, including<br />

RalA. Although not required for <strong>the</strong> exocytosis of synaptic vesicles,<br />

<strong>the</strong> exocyst may be important in o<strong>the</strong>r aspects of synapse growth and<br />

plasticity through its involvement in and regulation of <strong>the</strong> te<strong>the</strong>ring,<br />

docking and fusion of post-Golgi vesicles with <strong>the</strong> plasma membrane.<br />

I will present evi<strong>de</strong>nce of a signaling pathway by which synaptic<br />

activation can recruit <strong>the</strong> exocyst complex to postsynaptic zones and<br />

promote growth of postsynaptic membranes. For a more complete<br />

un<strong>de</strong>rstanding of <strong>the</strong> molecular pathways by which <strong>the</strong> exocyst<br />

contributes to synaptic <strong>de</strong>velopment, we did a forward genetic screen<br />

to i<strong>de</strong>ntify genes that interact with <strong>the</strong> exocyst member Sec5.<br />

Altoge<strong>the</strong>r, our studies i<strong>de</strong>ntified a novel pathway by which synaptic<br />

activity, with its concomitant influx of Ca2+, can contribute to <strong>the</strong><br />

<strong>de</strong>velopment of <strong>the</strong> post-synapse and, potentially, to a form of<br />

activity-<strong>de</strong>pen<strong>de</strong>nt plasticity involving membrane growth. Finally, we<br />

hope to fur<strong>the</strong>r un<strong>de</strong>rstand and dissect new pathways that contribute<br />

to synaptic <strong>de</strong>velopment and plasticity by uncovering new genes that<br />

genetically interact with exocyst.<br />

57


Host-Microorganism Interactions<br />

Luis Teixeira<br />

<strong>Instituto</strong> <strong>Gulbenkian</strong> <strong>de</strong> <strong>Ciência</strong><br />

Multicellular organisms and microorganisms are continuously<br />

interacting. Many of <strong>the</strong>se interactions are mutually beneficial.<br />

However, multicellular organisms have to actively thwart invasion by<br />

opportunistic or overtly pathogenic microbes. We are studying <strong>the</strong><br />

interaction of <strong>the</strong> mo<strong>de</strong>l organism Drosophila melanogaster with<br />

different microorganisms, in particular intracellular ones.<br />

D. melanogaster has been successfully used as a mo<strong>de</strong>l system to<br />

study innate immunity against many pathogens. Recently it has been<br />

shown that <strong>the</strong>re are innate immunity pathways against viruses<br />

conserved between insects and mammals. We are investigating<br />

mechanisms of resistance to viruses in <strong>the</strong> fruit fly.<br />

Interestingly, we have found that <strong>the</strong> intracellular bacteria Wolbachia<br />

confer resistance to RNA viruses in D. melanogaster. We want to<br />

un<strong>de</strong>rstand <strong>the</strong> molecular basis of this induced resistance.<br />

Finally, we are interested in <strong>the</strong> interplay between Drosophila and<br />

Wolbachia itself. These endosymbionts are one of <strong>the</strong> most<br />

wi<strong>de</strong>spread intracellular bacteria in <strong>the</strong> world but little is known, at<br />

<strong>the</strong> molecular level, on how <strong>the</strong> hosts control Wolbachia or Wolbachia<br />

manipulate <strong>the</strong> hosts.<br />

58


Into <strong>the</strong> molecular nature of <strong>the</strong> telomeric checkpoint Inhibition<br />

Tiago Carneiro and Miguel Godinho Ferreira<br />

<strong>Instituto</strong> <strong>Gulbenkian</strong> <strong>de</strong> <strong>Ciência</strong>, Oeiras, Portugal<br />

Telomeres, <strong>the</strong> natural chromosome ends of eukaryotes, have unique<br />

properties that distinguish <strong>the</strong>m from damage-induced DNA double<br />

strand breaks (DSB). Whereas a single DSB can halt cell cycle<br />

progression and activate repair processes, telomeres prohibit<br />

checkpoint activation and DNA repair. Never<strong>the</strong>less, several<br />

components involved in DNA damage response (DDR) are critical for<br />

end protection and must be controlled at telomeres to prevent<br />

checkpoints.<br />

We recently showed that telomeres constitute a chromatin-privileged<br />

region capable of stably mounting DDRs without blocking <strong>the</strong> cell<br />

cycle.<br />

Ra<strong>the</strong>r than preventing recruitment and activation of Rad3ATR<br />

kinase, telomeres exclu<strong>de</strong> <strong>the</strong> mediator Crb253BP1 protein thus<br />

preventing DDR amplification and full checkpoint response. In<br />

contrast to <strong>the</strong> rest of <strong>the</strong> genome, H4K20me2 (but not γH2A) is<br />

absent from telomeres. Lack of H4K20me2 from chromosome-ends<br />

cannot be explained by absence of Set9 methyltransferase. Not only<br />

telomeres exhibit Set9-<strong>de</strong>pen<strong>de</strong>nt mono and trimethylated forms of<br />

H4K20 but also artificial recruitment of Set9 to chromosome-ends<br />

does not restore a full checkpoint response.<br />

We are currently investigating how telomere heterochromatin<br />

exclu<strong>de</strong>s H4K20me2. We are <strong>de</strong>vising two complementary assays: 1-<br />

we hope to <strong>de</strong>termine sufficiency of telomere proteins to prevent<br />

checkpoints by te<strong>the</strong>ring <strong>the</strong>m adjacent to a HO-induced double<br />

strand break; 2- conversely, we are analysing internal telomere<br />

sequences to study whe<strong>the</strong>r <strong>the</strong>se are sufficient to modify <strong>the</strong><br />

surrounding chromatin and exclu<strong>de</strong> epigenetic markers required for<br />

checkpoint response.<br />

59


Fundraising for science-New approaches for research funding in<br />

Portugal<br />

Maria João Leão<br />

<strong>Instituto</strong> <strong>Gulbenkian</strong> <strong>de</strong> Ciencia, Lisboa, Portugal<br />

IGC has recently begun to <strong>de</strong>velop fundraising initiatives that involve<br />

<strong>the</strong> scientific community, <strong>the</strong> private sector and <strong>the</strong> general public.<br />

This project aims to establish alternative means of financial resources<br />

for research in Portugal and to contribute to a closer interaction<br />

between Research Institutions and <strong>the</strong> Portuguese society.<br />

60


Plenary Session<br />

Jonathan Howard<br />

Univeristy of Colgne, Germany<br />

“How to build a perfect institute”<br />

62


ABSTRACTS FOR ORAL PRESENTATIONS<br />

Tuesday 28 December<br />

SESSION FOUR<br />

64


The force of <strong>the</strong> pulsating collective<br />

Antonio Jacinto<br />

Insituto <strong>de</strong> Medicina Molecular, Lisboa<br />

We still do not know very much about coordination of forces<br />

generated by cells during morphogenesis. It amazes me how an<br />

entity with <strong>the</strong> complexity, fluidity, and softness of a cell can work<br />

with its neighbours to drive dynamic but extremely robust tissue<br />

shape changes that occur during embryogenesis or regeneration. I<br />

will tour recent results from our group that highlight <strong>the</strong> importance<br />

of non-monotonic cell behaviours; pulses of forces generated by <strong>the</strong><br />

actomyosin network seem to be one of <strong>the</strong> crucial strategies that cells<br />

use to work toge<strong>the</strong>r to produce from.<br />

66


Overview of <strong>the</strong> Cell Death Regulaion Laboratory<br />

Luis Miguel Martins<br />

Medical Research Council Toxicology, Leicester University, UK<br />

Tissue homeostasis relies on <strong>the</strong> tightly controlled removal of<br />

superfluous, damaged and ectopic cells, normally through apoptosis.<br />

Whereas an aberrant resistance to apoptosis participates in <strong>the</strong><br />

<strong>de</strong>velopment of neoplasias, excessive cell <strong>de</strong>ath, through apoptosis or<br />

necrosis, contributes to acute organ failure as well as to chronic<br />

diseases involving <strong>the</strong> loss of post-mitotic cells.<br />

The focus of our research is to better un<strong>de</strong>rstand <strong>the</strong> control of<br />

cellular <strong>de</strong>ath processes in normal cells as well as in pathological<br />

states where alterations of <strong>the</strong>se processes have occurred.<br />

Our aim is to achieve a better un<strong>de</strong>rstanding of <strong>the</strong> regulatory<br />

mechanisms controlling cell <strong>de</strong>ath. Un<strong>de</strong>rstanding <strong>the</strong> basic biology of<br />

<strong>the</strong>se processes can provi<strong>de</strong> insights that might lead to targeted<br />

treatment solutions that will act on pathways and alter disease at its<br />

cause resulting in a better type of medicine.<br />

67


Establishment of asymmetries in <strong>the</strong> early vertebrate embryo<br />

José António Belo<br />

(1) Regenerative Medicine Program, Departamento <strong>de</strong> <strong>Ciência</strong>s<br />

Biomédicas e Medicina, Universida<strong>de</strong> do Algarve, Portugal<br />

(2) IBB-Institute for Biotechnology and Bioengineering, Centro <strong>de</strong><br />

Biomedicina Molecular e Estrutural, Universida<strong>de</strong> do Algarve, Portugal<br />

(3) <strong>Instituto</strong> <strong>Gulbenkian</strong> <strong>de</strong> <strong>Ciência</strong>, Oeiras, Portugal<br />

One fundamental aspect of vertebrate embryonic <strong>de</strong>velopment is <strong>the</strong><br />

formation of <strong>the</strong> body plan. For this process, asymmetries have to be<br />

generated during early stages of <strong>de</strong>velopment along <strong>the</strong> three main<br />

body axes: Anterior-Posterior, Dorso-Ventral and Left-Right. We have<br />

been studying <strong>the</strong> role of a novel class of molecules, <strong>the</strong><br />

Cerberus/Dan gene family. These are <strong>de</strong>dicated secreted antagonists<br />

of three major signaling pathways: Nodal, BMP and Wnt. Our studies<br />

contribute to <strong>the</strong> current view that <strong>the</strong> fine tuning of signaling is<br />

controlled by a set of inhibitory molecules ra<strong>the</strong>r than by activators.<br />

In this context, <strong>the</strong> Cerberus-like molecules emerge as key players in<br />

<strong>the</strong> regulation and generation of asymmetries in <strong>the</strong> early vertebrate<br />

embryo. Recent studies conducted in our lab unraveled <strong>the</strong> role of<br />

<strong>the</strong>se molecules during organogenesis as well.<br />

68


Development on time: <strong>the</strong> embryonic molecular clock<br />

Isabel Palmeirim<br />

Medical and Biomedical Sciences Department, Bio-regenerative<br />

Medicine Program, IBB-Institute for Biotechnology and<br />

Bioengineering, Centre for Molecular and Structural Biomedicine,<br />

University of Algarve, Campus <strong>de</strong> Gambelas, 8005-139<br />

Alongsi<strong>de</strong> <strong>the</strong> three dimensions in which an embryo un<strong>de</strong>rgoes<br />

growth and differentiation, one can consi<strong>de</strong>r TIME as being a fourth<br />

dimension, which must experience equally tight regulatory<br />

mechanisms in or<strong>de</strong>r to assure that each tissue/structure/organ is<br />

formed in <strong>the</strong> right place, at <strong>the</strong> right time. Time control is<br />

particularly evi<strong>de</strong>nt during <strong>the</strong> process by which <strong>the</strong> vertebrate<br />

presomitic meso<strong>de</strong>rm is progressively segmented into repeated units,<br />

named somites. Somites arise in a highly coordinated way both in<br />

space and time and, later on, give rise to vertebrae, intervertebral<br />

discs, ribs and skeletal muscles. In 1997, <strong>the</strong> first molecular evi<strong>de</strong>nce<br />

for <strong>the</strong> existence of an intrinsic cellular molecular clock un<strong>de</strong>rlying <strong>the</strong><br />

rhythm of somitogenesis has been provi<strong>de</strong>d. We currently know that<br />

this clock operates in all vertebrate groups studied, in more than one<br />

embryonic tissue, with different time-periods and an increasing<br />

number of genes belonging to <strong>the</strong> Notch, FgF and Wnt<br />

signalling pathways are being implicated in this clocked mechanism.<br />

Recently, our work brings forth new results, evi<strong>de</strong>ncing <strong>the</strong> role of<br />

Shh signaling pathway in pacing molecular clock gene expression and<br />

timing morphological somite formation. We believe that a <strong>de</strong>eper<br />

un<strong>de</strong>rstanding of <strong>the</strong> role and regulation of this embryonic<br />

mechanism is of crucial importance, since temporal control of<br />

biological processes is a transversal issue in all life sciences research<br />

fields.<br />

69


NK cells in Preeclampsia<br />

Ana Sofia Cer<strong>de</strong>ira, Hernan D. Kopcow, Zaheed Husain, Agnes Lo,<br />

Caroline Royle, Ravi I. Thadhani, Isaac Stillman, Vikas P. Sukhatme<br />

and S. Ananth Karumanchi<br />

<strong>Gulbenkian</strong> Programme for Advanced Medical Education<br />

Beth Israel Deaconess Medical Center/Harvard Medical School<br />

Serviço <strong>de</strong> Ginecologia e Obstetricia Centro Hospitalar do Porto<br />

Preeclampsia is a pregnancy disease characterized by new onset<br />

hypertension and proteinuria. It is a leading cause of maternal and<br />

perinatal morbidity and mortality complicating 3-8% pregnancies.<br />

Recent evi<strong>de</strong>nce suggests that Natural Killer (NK) cell signaling at <strong>the</strong><br />

maternal-fetal interface is an important regulator of maternal spiral<br />

artery remo<strong>de</strong>ling. This process is impaired in preeclampsia and leads<br />

to increased expression of placental soluble factors such as sFlt1 that<br />

induce <strong>the</strong> systemic manifestations of <strong>the</strong> disease. NK cells are<br />

abundant at <strong>the</strong> maternal <strong>de</strong>cidua (dNK) during <strong>the</strong> first trimester of<br />

pregnancy, and show severely reduced cytotoxicity and secretion of<br />

proangiogenic factors like VEGF. In contrast, peripheral blood NK cells<br />

(pNK) are cytotoxic and non-angiogenic. We hypo<strong>the</strong>sized that a<br />

combination of hypoxia and immunosuppressive cytokines like TGF-<br />

β1, known to be present in <strong>the</strong> placenta, may turn pNKs into dNKlike<br />

proangiogenic cells with reduced cytotoxicity.<br />

Like dNKs, pNKs cultured un<strong>de</strong>r hypoxia secreted VEGF and induced<br />

tube formation by HUVECs. Un<strong>de</strong>r hypoxia in <strong>the</strong> presence of TGF-β1<br />

pNKs showed reduced cytotoxicity. Since placenta and tumor<br />

microenvironment share many features, we characterized tumor<br />

infiltrating NK cells (tiNK) to better un<strong>de</strong>rstand this phenomenon.<br />

tiNK cells isolated from kidney tumors, like dNKs, show reduced<br />

cytotoxicity and secrete VEGF. Moreover, pNK cells exposed to<br />

hypoxia and TGF-β1 support tumor growth in a mouse mo<strong>de</strong>l of<br />

cancer. The hypoxic and immunosuppressive microenvironment of<br />

both tumor and placenta may co-opt NK cells transforming <strong>the</strong>m into<br />

poorly cytotoxic cells that secrete VEGF. In vitro conversion of pNKs<br />

into angiogenic dNK-like cells may have potential applications in <strong>the</strong><br />

<strong>de</strong>velopment of novel <strong>the</strong>rapeutic approaches for preeclampsia.<br />

70


The heterogenous behavior of human breast cancer<br />

Sofia Braga (1,2,3) and José B. Pereira-Leal (1)<br />

(1) <strong>Instituto</strong> <strong>Gulbenkian</strong> <strong>de</strong> <strong>Ciência</strong> - Oeiras, Portugal<br />

(2) <strong>Instituto</strong> Português <strong>de</strong> Oncologia - Lisboa, Portugal<br />

(3) Programa <strong>Gulbenkian</strong> <strong>de</strong> Formação Médica Avançada<br />

BC is a heterogenous disease. There are three subtypes of BC,<br />

<strong>de</strong>fined by immunohistochemical <strong>de</strong>tection of specific proteins, with<br />

prognostic and <strong>the</strong>rapeutic implications: ER positive BC, half of which<br />

also express <strong>the</strong> PgR, Her2 positive BC, and Triple negative BC. ER+<br />

BC is generally consi<strong>de</strong>red easier to manage clinically because of <strong>the</strong><br />

sensitivity to anti-estrogenic <strong>the</strong>rapy, Her2+ is treated with anti-Her2<br />

<strong>the</strong>rapy but has worse prognosis and TNBC has no validated targeted<br />

<strong>the</strong>rapy having <strong>the</strong> worse prognosis. Clinicians observe heterogeneity<br />

in <strong>the</strong> outcome of BC: not all ER+ BC are cured, some Her2+ BC<br />

relapse during <strong>the</strong>rapy and not all TNBC have a uniformly dismal<br />

prognosis. Our goal is to dissect <strong>the</strong> molecular basis of this<br />

heterogeneity. We already compiled and analyzed publicly available<br />

expression data (microarrays) from 3500 human tumors with<br />

outcome annotation. We performed subtype selection by standard<br />

immunohistochemical annotation and by using a computational<br />

algorithm. We used classical supervised methods for discovering<br />

genes and pathways that are differentially expressed in tumours with<br />

differing outcome. We have generated a set of potential prognostic<br />

markers for each subtype of BC that we are now fur<strong>the</strong>r<br />

investigating. The next step in this analysis is a prospective<br />

validation of <strong>the</strong> prognostic value of <strong>the</strong>se genes and pathways in<br />

collaboration with pathologists at public hospitals in Lisbon.<br />

71


Different tasks, different tra<strong>de</strong>offs: speed and accuracy in odor<br />

<strong>de</strong>tection vs. odor categorization<br />

Maria I. Vicente, André G. Mendonça, Zachary F. Mainen<br />

Systems Neuroscience Lab, Champalimaud Neuroscience Programme<br />

Speed-accuracy tra<strong>de</strong>offs (SATs) are well known in cognitive and<br />

perceptual <strong>de</strong>cision-making, and can involve large (>50%) changes<br />

in processing time. However, in some tasks, such as odor mixture<br />

categorization, much smaller SATs (or<strong>de</strong>r 10%) are observed. Why<br />

some tasks benefit more from temporal processing than o<strong>the</strong>rs is not<br />

well un<strong>de</strong>rstood.<br />

We hypo<strong>the</strong>size that <strong>the</strong> <strong>de</strong>gree of SAT <strong>de</strong>pends on <strong>the</strong> relative<br />

contribution of sensory and non-sensory noise. To test this i<strong>de</strong>a, we<br />

compared SAT in <strong>the</strong> odor mixture categorization task to that in a<br />

new two alternative choice odor <strong>de</strong>tection task, using <strong>the</strong> same odors<br />

diluted up to 1,000-fold. The same rats performed both tasks and all<br />

o<strong>the</strong>r task variables were held constant. We envisaged that stimulus<br />

noise would dominate <strong>the</strong> <strong>de</strong>tection but not <strong>the</strong> categorization task.<br />

As predicted, we found that SAT (difference in reaction time, RT, from<br />

<strong>the</strong> easiest to <strong>the</strong> har<strong>de</strong>st problem) was much larger in <strong>the</strong> odor<br />

<strong>de</strong>tection task (53% increase in RT as accuracy <strong>de</strong>creased from 97%<br />

to 62%) than in <strong>the</strong> mixture categorization task (14% increase for a<br />

similar change in accuracy). These data <strong>de</strong>monstrate that sensory<br />

integration and <strong>the</strong> amount of SAT are problem-specific and suggest<br />

that <strong>the</strong> locus of performance-limiting noise is a critical variable.<br />

72


Chromatin dynamics in motor skill learning<br />

Galvão-Ferreira P. and Costa R. M.<br />

Champalimaud Neuroscience Program at <strong>Instituto</strong> <strong>Gulbenkian</strong> <strong>de</strong><br />

Ciencia, Rua da Quinta Gran<strong>de</strong> 6, 2781-901 Oeiras, Portugal<br />

Motor skills can last a lifetime. In previous work, we have shown that<br />

motor skill learning involves changes in synaptic plasticity in <strong>the</strong><br />

striatum which evolve with training. In addition, we observed<br />

differential involvement of striatal output circuits (namely,<br />

striatonigral and striatopallidal circuits) in skill authomatization. In<br />

recent years, both DNA methylation and post-translational<br />

modifications of nuclear proteins have been implicated in<br />

physiologically normal mechanisms (such as synaptic plasticity and<br />

memory formation) as well as in neuropathological contexts. Yet, <strong>the</strong><br />

involvement of <strong>the</strong>se epigenetic mechanisms in motor skill learning<br />

has not been investigated.<br />

To test for <strong>the</strong> involvement of <strong>the</strong>se biochemical mechanisms in skill<br />

learning, we trained young and old mice (2 and 8 months old,<br />

respectively) in a lever-pressing task, in which subjects had to press<br />

<strong>the</strong> lever at up to 8Hz. Next, using DRD1-GFP and DRD2-GFP reporter<br />

mice to distinguish between D1-expressing and D2-expressing<br />

medium spiny (respectively, striatonigral and striatopallidal) neurons,<br />

we inquired whe<strong>the</strong>r epigenetic changes could be found in <strong>the</strong>se two<br />

circuits through immunohistochemistry and Western blotting.<br />

Currently, we are using those same transgenic mouse lines in an<br />

effort to extract and purify striatonigral and striatopallidal neurons<br />

through fluorescent activated cell sorting (FACS). Using <strong>the</strong>se varied<br />

approaches, we intend to investigate if <strong>the</strong> long-lasting plasticity<br />

observed throughout skill learning involves <strong>de</strong>fined epigenetic<br />

mechanisms in <strong>the</strong> striatonigral and striatopallidal output circuits.<br />

73


Plenary Session<br />

Maria Leptin, EMBO, Germany<br />

“My Life in Science”<br />

74


Alexandra Borges<br />

Participants List<br />

<strong>Instituto</strong> <strong>de</strong> Investigaciones Biomédicas Alberto Sols, Spain<br />

borgalexandra@gmail.com<br />

Alexandra Capela<br />

StemCells Inc, USA<br />

alexandra.capela@stemcellsinc.com<br />

Alexandra Santos<br />

King's College London, Hospitais da Universida<strong>de</strong> <strong>de</strong> Coimbra, UK<br />

alexandrafigueirasantos@gmail.com<br />

Alexandre Raposo<br />

<strong>Instituto</strong> <strong>Gulbenkian</strong> <strong>de</strong> <strong>Ciência</strong><br />

araposo@igc.gulbenkian.pt<br />

Ana Borges<br />

<strong>Instituto</strong> <strong>Gulbenkian</strong> <strong>de</strong> <strong>Ciência</strong>, PT<br />

aborges@igc.gulbenkian.pt<br />

Ana Campilho<br />

IBMC, PT<br />

anacampilho@ibmc.up.pt<br />

76


Ana Mateus<br />

Cambridge University, UK<br />

amam3@cam.ac.uk<br />

Ana Matos<br />

<strong>Instituto</strong> <strong>Gulbenkian</strong> <strong>de</strong> <strong>Ciência</strong><br />

anamatos.ct.surgery@gmail.com<br />

Ana Sousa<br />

Hospital <strong>de</strong> Santa Maria, PT<br />

anabertasousa@gmail.com<br />

Ana Sofia Cer<strong>de</strong>ira<br />

Beth Israel Deconess Medical Center, USA<br />

ana.cer<strong>de</strong>ira@gmail.com<br />

Ana Teresa Tavares<br />

CIISA-FMV, PT<br />

atavares@igc.gulbenkian.pt<br />

Ana Sanchez<br />

ITQB, PT<br />

asanchez@itqb.unl.pt<br />

77


António Coutinho<br />

<strong>Instituto</strong> <strong>Gulbenkian</strong> <strong>de</strong> <strong>Ciência</strong><br />

coutinho@igc.gulbenkian.pt<br />

António Jacinto<br />

Inst. <strong>de</strong> Medicina Molecular, Fac. <strong>de</strong> Medicina da Univ. <strong>de</strong> Lisboa, PT<br />

ajacinto@fm.ul.pt<br />

Carla Martins<br />

Cancer Research, UK<br />

Carla.Martins@cancer.org.uk<br />

Catarina Homem<br />

Inst. of Molecular Biotech. of <strong>the</strong> Austrian Ac. of Sciences (IMBA), AUSTRIA<br />

catarina.homem@imba.oeaw.ac.at<br />

Cátia Proença<br />

<strong>Gulbenkian</strong>/Weill Cornell, USA<br />

cproenca@igc.gulbenkian.pt<br />

César Evaristo<br />

University of Chicago, USA<br />

cesar.evaristo@gmail.com<br />

78


Cláudio Gomes<br />

ITQB<br />

gomes@itqb.unl.pt<br />

David Cristina<br />

<strong>Instituto</strong> <strong>Gulbenkian</strong> da <strong>Ciência</strong>, PT<br />

davidc@igc.gulbenkian.pt<br />

Dinis Calado<br />

Harvard Medical School, USA<br />

calado@idi.harvard.edu<br />

Diogo Castro<br />

<strong>Instituto</strong> <strong>Gulbenkian</strong> <strong>de</strong> <strong>Ciência</strong>, PT<br />

dscastro@igc.gulbenkian.pt<br />

Diogo Lucena<br />

<strong>Fundação</strong> <strong>Calouste</strong> <strong>Gulbenkian</strong><br />

dlucena@gulbenkian.pt<br />

79


Diogo Pimentel<br />

DPAG- Oxford University, UK<br />

d.o.pimentel@gmail.com<br />

Eduardo Silva<br />

Wyss Institute/ Harvard University, USA<br />

easilva@wyss.harvard.edu<br />

Filipa Barbosa<br />

Insituto <strong>Gulbenkian</strong> <strong>de</strong> <strong>Ciência</strong><br />

fbarbosa@igc.gulbenkian.pt<br />

Filipe Martins<br />

Dana-Farber Cancer Institute, UK<br />

filipecorreiamartins@gmail.com<br />

Francisco Dionísio<br />

Centro <strong>de</strong> Biologia Ambiental, Fac. <strong>de</strong> <strong>Ciência</strong>s Univ. <strong>de</strong> Lisboa, PT<br />

francisco.dionisio@gmail.com<br />

Fre<strong>de</strong>rico Regateiro<br />

University of Oxford, UK<br />

regateiro@gmail.com<br />

80


Guilherme Neves<br />

Molecular Neurobiology Div., MRC- Nat. Inst. for Medical Research, UK<br />

gneves@nimr.mrc.ac.uk<br />

Greta Martins<br />

<strong>Instituto</strong> <strong>Gulbenkian</strong> <strong>de</strong> <strong>Ciência</strong><br />

gmartins@igc.gulbenkian.pt<br />

Helena Soares<br />

Pasteur Institute, FR<br />

helena.soares@pasteur.fr<br />

Inês Pires da Silva<br />

New York University, USA<br />

inespiresilva@gmail.com<br />

Isabel Campos<br />

IMM, PT<br />

icampos@fm.ul.pt<br />

Isabel Duarte<br />

<strong>Instituto</strong> <strong>Gulbenkian</strong> <strong>de</strong> <strong>Ciência</strong>, PT<br />

iduarte@igc.gulbenkian.pt<br />

81


Isabel Gordo<br />

<strong>Instituto</strong> <strong>Gulbenkian</strong> <strong>de</strong> <strong>Ciência</strong>, PT<br />

igordo@igc.gulbenkian.pt<br />

Isabel Palmeirim<br />

<strong>Instituto</strong> <strong>Gulbenkian</strong> <strong>de</strong> <strong>Ciência</strong>, PT<br />

palmeiri@igc.gulbenkian.pt<br />

Joana Barros<br />

Associação viver a ciência, PT<br />

jbarros@viveraciencia.org<br />

Joana Sá<br />

Harvard University, USA<br />

mjsa@fas.harvard.edu<br />

Joana Santos<br />

<strong>Instituto</strong> <strong>Gulbenkian</strong> <strong>de</strong> <strong>Ciência</strong>, PT<br />

joanars@igc.gulbenkian.pt<br />

Jonathan Howard<br />

Institute for Genetics<br />

82


José A. Belo<br />

Dep. <strong>de</strong> <strong>Ciência</strong>s Biomédicas e Medicina, Univ. Do Algarve, PT<br />

jbelo@ualg.pt<br />

José Antão<br />

Massachusetts General Hospital, USA<br />

antao@molbio.mgh.harvard.edu<br />

José Leal<br />

<strong>Instituto</strong> <strong>Gulbenkian</strong> <strong>de</strong> <strong>Ciência</strong>, PT<br />

jleal@igc.gulbenkian.pt<br />

Leonor Parreira<br />

Universida<strong>de</strong> <strong>de</strong> Lisboa, Faculda<strong>de</strong> <strong>de</strong> Medicina/ IGC<br />

lparreir@igc.gulbenkian.pt<br />

Lília Perfeito<br />

University of Cologne, GER<br />

lilia.perfeito@gmail.com<br />

L. Miguel Martins<br />

MRC Toxicology Unit, UK<br />

martins.lmiguel@gmail.com<br />

83


Luís Graça<br />

<strong>Instituto</strong> <strong>de</strong> Medicina Molecular, PT<br />

lgraca@fm.ul.pt<br />

Luis Soares<br />

Harvard Medical School, UK<br />

luis_soares@hms.harvard.edu<br />

Luis Teixeira<br />

<strong>Instituto</strong> <strong>Gulbenkian</strong> <strong>de</strong> <strong>Ciência</strong>, PT<br />

lteixeira@igc.gulbenkian.pt<br />

Manuel Batista<br />

Skirball Institute NYU, USA<br />

mfscb2@googlemail.com<br />

Manuel Rebelo<br />

<strong>Instituto</strong> <strong>Gulbenkian</strong> <strong>de</strong> <strong>Ciência</strong>, PT<br />

mrebelo@igc.gulbenkian.pt<br />

Margarida Trinda<strong>de</strong><br />

IMM, PT<br />

mtrinda<strong>de</strong>@fm.ul.pt<br />

84


Maria Inês Vicente<br />

Champalimaud Neuroscience Program at IGC, PT<br />

mivicente@igc.gulbenkian.pt<br />

Maria Leptin<br />

EMBO, Germany<br />

Maria Luisa Vasconcelos<br />

CNP at <strong>Instituto</strong> <strong>Gulbenkian</strong> <strong>de</strong> <strong>Ciência</strong>, PT<br />

vasconcelos@igc.gulbenkian.pt<br />

Maria João Leão<br />

<strong>Instituto</strong> <strong>Gulbenkian</strong> <strong>de</strong> <strong>Ciência</strong>, PT<br />

mjleao@igc.gulbenkian.pt<br />

Marta Nunes<br />

University of <strong>the</strong> Witwatersrand, SOUTH AFRICA<br />

mnunes00@yahoo.com<br />

Miguel Gaspar<br />

mangerico@gmail.com<br />

85


Miguel God. Ferreira<br />

<strong>Instituto</strong> <strong>Gulbenkian</strong> <strong>de</strong> <strong>Ciência</strong>, PT<br />

mgferreira@igc.gulbenkian.pt<br />

Miguel Remon<strong>de</strong>s<br />

MIT, USA<br />

remon<strong>de</strong>s@mit.edu<br />

Mónica Dias<br />

<strong>Instituto</strong> <strong>Gulbenkian</strong> da <strong>Ciência</strong>, PT<br />

mdias@igc.gulbenkian.pt<br />

Mónica Sousa<br />

IBMC, PT<br />

msousa@ibmc.up.pt<br />

Nuno Costa<br />

Institute of Neuroinformatics, Switzerland<br />

ndacosta@ini.phys.ethz.ch<br />

Ofélia P. De Carvalho<br />

University of Cambridge, UK<br />

omc20@cam.ac.uk<br />

86


Paula Duque<br />

<strong>Instituto</strong> <strong>Gulbenkian</strong> <strong>de</strong> <strong>Ciência</strong>, PT<br />

duquep@igc.gulbenkian.pt<br />

Paulo Ribeiro<br />

London Research Institute, Cancer Research, UK<br />

paulo.ribeiro@cancer.org.uk<br />

Pedro Batista<br />

Wake Forest Institute for Regenerative Medicine, USA<br />

pbaptist@wfubmc.edu<br />

Pedro Brites<br />

IBMC, PT<br />

pedro.brites@ibmc.up.pt<br />

Pedro Domingos<br />

ITQB, PT<br />

domingp@itqb.unl.pt<br />

Pedro Ferreira<br />

Champalimaud Neuroscience Program at IGC, PT<br />

pferreira@igc.gulbenkian.pt<br />

87


Perpétua Pinto-do-Ó<br />

INEB-<strong>Instituto</strong> Nacional <strong>de</strong> Engenharia Biomédica, PT<br />

perpetua@ineb.up.pt<br />

Ricardo Almeida<br />

University of Edinburgh, UK<br />

r.almeida@ed.ac.uk<br />

Ricardo Costa<br />

Centro Nacional <strong>de</strong> Investigaciones Cardiovasculares – CNIC, SP<br />

ricardo.costa@cnic.es<br />

Ricardo Neto Silva<br />

Champalimaud Neuroscience Programme at <strong>Instituto</strong> <strong>Gulbenkian</strong> <strong>de</strong> <strong>Ciência</strong>, PT<br />

ricmigneto@gmail.com<br />

Rita Sousa Nunes<br />

National Institute for Medical Research (NIMR), UK<br />

rsousa@nimr.mrc.ac.uk<br />

Rita Tavares<br />

University of California, San Francisco, USA<br />

ritamtavares@gmail.com<br />

88


Rita Teodoro<br />

Harvard Medical School, USA<br />

roteodoro@yahoo.com<br />

Rui Goncalo Martinho<br />

<strong>Instituto</strong> <strong>Gulbenkian</strong> <strong>de</strong> <strong>Ciência</strong>, PT<br />

rmartinho@igc.gulbenkian.pt<br />

Rui Peixoto<br />

<strong>Instituto</strong> <strong>Gulbenkian</strong> <strong>de</strong> <strong>Ciência</strong><br />

rmartinho@igc.gulbenkian.pt<br />

Severina Moreira<br />

University of Bristol, UK<br />

severina_moreira@hotmail.com<br />

Sheila Vidal<br />

<strong>Instituto</strong> <strong>Gulbenkian</strong> <strong>de</strong> <strong>Ciência</strong>, PT<br />

svidal@igc.gulbenkian.pt<br />

Silvia Costa<br />

ISPA, PT<br />

silviasantoscosta@gmail.com<br />

89


Sofia Araujo<br />

IBMB-CSIC, SPAIN<br />

sofia.araujo@irbbarcelona.org<br />

Sofia Braga<br />

<strong>Instituto</strong> <strong>Gulbenkian</strong> <strong>de</strong> <strong>Ciência</strong>, PT<br />

sbraga@igc.gulbenkian.pt<br />

Susana Vaz Nery<br />

CISA PROJECT, ANGOLA<br />

susana.nery@gmail.com<br />

Tiago Botelho<br />

IBMB-CSIC, SP<br />

tobcri@ibmb.csic.es<br />

Tiago Carneiro<br />

<strong>Instituto</strong> <strong>Gulbenkian</strong> <strong>de</strong> <strong>Ciência</strong>, PT<br />

tcarneir@igc.gulbenkian.pt<br />

Tiago Carvalho<br />

LabOr<strong>de</strong>rs, PT<br />

tiago@labor<strong>de</strong>rs.com<br />

90


Ulla-Maj Fiuza<br />

No instituition affiliation<br />

umfiuza@igc.gulbenkian.pt<br />

Vasco Barreto<br />

<strong>Instituto</strong> <strong>Gulbenkian</strong> <strong>de</strong> <strong>Ciência</strong>, PT<br />

vbarreto@igc.gulbenkian.pt<br />

Vanessa Luis<br />

<strong>Instituto</strong> <strong>de</strong> Medicina Molecular, PT<br />

vluis@fm.ul.pt<br />

Vera Teixeira<br />

<strong>Instituto</strong> <strong>de</strong> Medicina Molecular, PT<br />

teixeira@igc.gulbenkian.pt<br />

91

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!